P (2010-2017)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2017

+Studies in 2000-2009 List
*Studies in Pre-2000 List

PAIN*+
PANCREAS/PANCREATITIS +
PANHYPOPITUITARISM (See News Articles 2010-2017)
PARKINSON’S DISEASE*+
PATENTS RELATED TO CANNABIS*+
PERINATAL ASPHYXIA (Brain Damage Due To A Lack Of Oxygen During Birth)
PERINATAL HYPOXIC-ISCHEMIC INJURY (Stroke in Infants, See Also STROKES)
PHANTOM LIMB SYNDROME + (See News Articles 2010-2017)
PHARC/POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA and CATARACT SYNDROME
PLACEBO EFFECT +
POISONING-HEAVY METAL*+
POISONING-ORGANOPHOSPHATE +
POISONING-OTHER
POISONING-PARAQUAT*+
POISONING–ROTENONE
POLLS and SURVEYS
PORPHYRIA (See News Articles 2010-2017)
POST-OPERATIVE PAIN +
POLLUTION/ENVIRONMENT (See Also DRUG TESTING–WASTEWATER)
POST POLIO SYNDROME +
POST-TRAUMATIC STRESS DISORDER/FEAR EXTINCTION +
POTENCY
PRADER WILLI SYNDROME
PREGNANCY/PRENATAL EXPOSURE*+ (See Also PERINATAL HYPOXIC-ISCHEMIC INJURY, CHILDREN/YOUNG ADULTS)
PRIONS +
PROMM/PROXIMAL MYOTONIC MYOPATHY (See 2000-2009 List)
PROSTATIC HYPERPLASIA/BPH/ENLARGED PROSTATE GLAND
PRURITIS + (Chronic Itch)
PSEUDOMONAS AERUGINOSA
PSORIASIS +
top


PAIN
Evidence for a Role of Endocannabinoids, Astrocytes and p38 Phosphorylation in the Resolution of Postoperative Pain (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878341/?tool=pmcentrez
Endocannabinoid involvement in endometriosis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972363/
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2871326/
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260554/
Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain (full-2010) http://www.jpsmjournal.com/article/S0885-3924%2809%2900787-8/fulltext
Historical essay: An Arabic surgeon, Ibn al Quff’s (1232-1286) account on surgical pain relief (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173333/
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System. (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033984/
Cannabinoid receptor-mediated antinociception with acetaminophen drug combinations in rats with neuropathic spinal cord injury pain (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2826109/ The Role of Cannabinoid Receptors in the Descending Modulation of Pain (link to PDF-2010) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.634.4866&rank=72
Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic neuralgia (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19744255
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1265622
Role of cannabinoids in the treatment of pain and (painful) spasticity (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21142261
Electroacupuncture increases CB2 receptor expression on keratinocytes and infiltrating inflammatory cells in inflamed skin tissues of rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20627823
Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20705472
A catalytically silent FAAH-1 variant drives anandamide transport in neurons (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245783/
top
Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249239/
Palmitoylethanolamide reduces granuloma-induced hyperalgesia by modulation of mast cell activation in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034677/?tool=pubmed
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief (full–2011) http://www.hindawi.com/isrn/anesthesiology/2011/593894/
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3041249/
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104059/
Sex Differences in Cannabinoid 1 vs. Cannabinoid 2 Receptor-Selective Antagonism of Antinociception Produced by Δ9-Tetrahydrocannabinol and CP55,940 in the Rat (full–2011) http://jpet.aspetjournals.org/content/340/3/787.full
Pharmacological characterization of AM1710, a putative cannabinoid CB(2) agonist from the cannabilactone class: Antinociception without central nervous system side-effects (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3089437/pdf/nihms280008.pdf
Cannabinoids for Treatment of Chronic Non-Cancer Pain; a Systematic Review of
Randomized Trials (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/
Fatty acid amide hydrolase blockade attenuates the development of collagen-induced arthritis and related thermal hyperalgesia in mice (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164582/
Mouse models for studying pain in sickle disease: effects of strain, age, and acuteness (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3779783/
High levels of N-palmitoylethanolamide and N-stearoylethanolamide in microdialysate samples from myalgic trapezius muscle in women (full–2011) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0027257
Cannabinoid potentiation of glycine receptors contributes to cannabis-induced analgesia (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388539/
Cannabinoids attenuate cancer pain and proliferation in a mouse model (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3099480/
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentyl-phenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as analgesics, anti-inflammatory and antidiarrheal agents (full–2011) https://www.google.com/patents/US7884133?dq=patent+7884133&hl=en&sa=X&ei=Ujb0U_6EEIW5ogSl84LYDg&ved=0CB4Q6AEwAA
TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Δ9-tetrahydrocannabiorcol (full–2011) http://www.nature.com/ncomms/journal/v2/n11/full/ncomms1559.html
The intersection between cannabis and cancer in the United States (full–2011) http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Cannabis in Palliative Medicine: Improving Care and Reducing Opioid-Related Morbidity (link to download-2011) http://ajh.sagepub.com/content/28/5/297
Treating pain in multiple sclerosis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21916786
top
Effects of repeated electroacupuncture on gene expression of cannabinoid receptor-1 and dopamine 1 receptor in nucleus accumbens-caudate nucleus region in inflammatory-pain rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21585053
Cannabinoid-opioid interaction in chronic pain (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/22048225/abstract/Cannabinoid_opioid_interaction_in_chronic_pain_
Antinociception and sedation following intracerebroventricular administration of Δ⁹-tetrahydrocannabinol in female vs. male rats (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20692296/abstract/Antinociception_and_sedation_following_intracerebroventricular_administration_of_%CE%94%E2%81%B9_tetrahydrocannabinol_in_female_vs__male_rats_
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21624393
A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21864979
FROM GHENNAB TO CANNABIS: HOPES TO FIND A CURE FOR MULTIPLE SCLEROSIS ARE FLOURISHING (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=228000
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
The periaqueductal gray contributes to bidirectional enhancement of antinociception between morphine and cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959123/
Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02179.x/full
Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs spinally-innervated skin (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394407/
“Redundancy” of endocannabinoid inactivation: new challenges and opportunities for pain control (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382450/
Therapeutic modulation of cannabinoid lipid signaling: Metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493696/
top
Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm? (full-2012) http://onlinelibrary.wiley.com/doi/10.1002/art.34522/full
The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level (full–2012) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2012/06000/The_Effects_of_Peptide_and_Lipid_Endocannabinoids.30.aspx
Synergistic interaction of pregabalin with the synthetic cannabinoid WIN 55,212-2 mesylate in the hot-plate test in mice: an isobolographic analysis (full–2012) http://www.if-pan.krakow.pl/pjp/pdf/2012/3_723.pdf
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Non-inflammatory Pain (full–2012) http://jpet.aspetjournals.org/content/338/1/114.full
Cannabidiol in humans-the quest for therapeutic targets (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/24281562
The fatty acid amide hydrolase (FAAH) inhibitor PF-3845 acts in the nervous system to reverse LPS-induced tactile allodynia in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423256/
The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyper-algesia in patients with neuromyelitis optica (full–2012) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071500
Neonatal DSP-4 Treatment Modifies Antinociceptive Effects of the CB(1) Receptor Agonist Methanandamide in Adult Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526738/
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578305/
Activation of Type 5 Metabotropic Glutamate Receptors and Diacylglycerol Lipase-α Initiates 2-Arachidonoylglycerol Formation and Endocannabinoid-Mediated Analgesia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652685/
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366638/
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy (full–2012) http://www.molecularpain.com/content/8/1/71
Endocannabinoid modulation of jejunal afferent responses to LPS (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2012.01961.x/full
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
Targeting Fatty Acid Binding Protein (FABP) Anandamide Transporters – A Novel Strategy for Development of Anti-Inflammatory and Anti-Nociceptive Drugs (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0050968
top
Mast cell-glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3312.long
Monoacylglycerol lipase – a target for drug development? (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.01950.x/pdf
Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603341/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Cannabinoids and muscular pain. Effectiveness of the local administration in rat (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22354705
Behavioral effects of pulp exposure in mice lacking cannabinoid receptor 2 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22152627
Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized controlled Trial Results (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22367503
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
Role of cannabinoid 2 receptor in the development of bone cancer pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22490961
Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial (abst-2012) http://www.sciencedirect.com/science/article/pii/S1526590012000193
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337336
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22201038
Acute Reduction of Anandamide-Hydrolase (FAAH) Activity is Coupled With a Reduction of Nociceptive Pathways Facilitation in Medication-Overuse Headache Subjects After Withdrawal Treatment (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1526-4610.2012.02170.x/abstract
Analgesic effects of cannabinoids on central pain syndrome (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22359935
Cannabis as an adjunct to or substitute for opiates in the treatment of chronic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22880540
Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22954177
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/syn.21586/abstract
Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23138934
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337285
Palmitoylethanolamide versus a nonsteroidal anti-inflammatory drug in the treatment of temporomandibular joint inflammatory pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22558609
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists in rhesus monkeys: antinociception, drug discrimination, and drug self-administration (full–2013) http://jpet.aspetjournals.org/content/early/2013/03/27/jpet.113.204099.long
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in
anti-nociceptive responses after experimental spinal cord injury (full–2013) http://www.sciencedirect.com/science/article/pii/S0306452213007835
Differential modulation of nociceptive versus non-nociceptive synapses by endocannabinoids (full–2013) http://www.molecularpain.com/content/pdf/1744-8069-9-26.pdf
The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0071500
Role of endogenous cannabinoid system in the gut (full-2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643547/
The monoacylglycerol lipase inhibitor JZL184 suppresses inflammatory pain in the mouse carrageenan model (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717616/
Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080440
top
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist (full–2013) http://www.molecularpain.com/content/9/1/32
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730365/
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Cannabinoid receptors and pain (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/wmts.83/full
Amygdala activity contributes to the dissociative effect of cannabis on pain perception (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549497/
Dissociation of the Pharmacological Effects of THC by mTOR Blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656376/
Pro-resolution, protective and anti-nociceptive effects of a cannabis extract in the rat gastrointestinal tract (full–2013) http://www.jpp.krakow.pl/journal/archive/04_13/pdf/167_04_13_article.pdf
CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System (full–2013) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2013/02000/CB1_and_CB2_Cannabinoid_Receptor_Agonists_Induce.31.aspx
top
Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657109/
The cannabinoid-1 receptor inverse agonist taranabant reduces abdominal pain and increases intestinal transit in mice (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12158/full
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753184/
The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870904/
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752375/
Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana In Daily Marijuana Smokers (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746706/
The Subjective Psychoactive Effects of Oral Dronabinol Studied in a Randomized, Controlled Crossover Clinical Trial For Pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4013220/
Targeting the cannabinoid system for pain relief? (full–2013) http://www.e-aat.com/article/S1875-4597%2813%2900119-7/fulltext
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care (full–2013) http://cannabisclinicians.org/wp-content/uploads/2013/09/Med-Nec-for-Cannabis-in-Cancer-Israel.pdf
The use of cannabinoids in chronic pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23893276
Endocannabinoid and cannabinoid-like fatty acid amide levels correlate with pain-related symptoms in patients with IBS-D and IBS-C: a pilot study (full–2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0085073
β-Arrestins: Regulatory Role and Therapeutic Potential in Opioid and Cannabinoid Receptor-Mediated Analgesia (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804701/
Different Classes of CB2 Ligands Potentially Useful in the Treatment of Pain (link to PDF–2013) http://www.eurekaselect.com/108399/article
The role of endocannabinoids in pain modulation (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/fcp.12008/pdf
Interactions between mu opioid receptor agonists and cannabinoid receptor agonists CP55940 and WIN55212-2 in rhesus monkeys: evaluation of treatment- and abuserelated effects (abst–2013) http://www.fasebj.org/content/27/1_Supplement/1097.3.abstract?sid=b188b212-67f6-4544-827b- 5e857c313f2e
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23518609
Involvement of the opioid and cannabinoid systems in pain control: new insights from knockout studies (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23523475
Endocannabinoids: A unique opportunity to develop multitarget analgesics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23623250
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23669059
Effects of the cannabinoid 2 receptor-selective agonist GW405833 in assays of acute pain-stimulated and paindepressed behavior in rats (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/886.9?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists (abst–2013) http://pubs.acs.org/doi/abs/10.1021/jm4005626
Sex differences in anti-allodynic, anti-hyperalgesic and anti-edema effects of Δ9-tetrahydrocannabinol in the rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23707295
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electro-acupuncture on experimental arthritis of the rat temporomandibular joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
Administration of micronized palmitoylethanolamide (PEA)-transpolydatin in the treatment of chronic pelvic pain in women affected by endometriosis: preliminary results (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24051945
Pharmacology of Cannabinoid Receptor Agonists and a Cyclooxygenase-2 Inhibitor in Rat Bone Tumor Pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24008428
Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23784345
Palmitoylethanolamide and stearoylethanolamide levels in the interstitium of the trapezius muscle of women with chronic widespread pain and chronic neck-shoulder pain correlate with pain intensity and sensitivity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23707281
Anandamide produced by Ca2+-insensitive enzymes induces excitation in primary sensory neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24114173
Peripheral and Spinal Activation of Cannabinoid Receptors by Joint Mobilization Alleviates Postoperative Pain in Mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24120553
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148812
The adjuvant use of N-palmitoylethanolamine and transpolydatin in the treatment of endometriotic pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23415738
Endocannabinoids: a unique opportunity to develop multitarget analgesics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23623250
Postoperative Analgesia in the Jamaican Cannabis User (abst–2013) http://www.tandfonline.com/doi/full/10.1080/02791072.2013.803644#.U9QCtWN8E24
New insights in mast cell modulation by palmitoylethanolamide (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394523
Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394519
Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and transcutaneous electrical nerve stimulation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23343704
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists (abst–2013) http://pubs.acs.org/doi/abs/10.1021/jm4005626
A Systems Pharmacology Perspective on the Clinical Development of Fatty Acid Amide Hydrolase Inhibitors for Pain (full–2014) http://www.nature.com/psp/journal/v3/n1/full/psp201372a.html
top
Inhibition of Fatty Acid binding proteins elevates brain anandamide levels and produces analgesia (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976407/
The consequences of pain in early life: injury-induced plasticity in developing pain pathways (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264936/
CB2 cannabinoid receptors as a therapeutic target – What does the future hold? (full–2014) http://molpharm.aspetjournals.org/content/early/2014/08/08/mol.114.094649.long
Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology (full-2014) http://www.neurology.org/content/82/17/1556.long
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia (full–2014) http://www.sciencedirect.com/science/article/pii/S0306452213010531
Prolonged monoacylglycerol lipase blockade causes equivalent CB1-receptor mediated adaptations in FAAH wild type and knockout mice (full–2014) http://jpet.aspetjournals.org/content/early/2014/05/21/jpet.114.212753.long
Heterogeneous presynaptic distribution of monoacylglycerol lipase, a multipotent regulator of nociceptive circuits in the mouse spinal cord (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979158/
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
R-flurbiprofen attenuates experimental autoimmune encephalomyelitis in mice (full–2014) http://embomolmed.embopress.org/content/6/11/1398.long
top
Impact of efficacy at the mu opioid receptor on antinociceptive effects of combinations of mu opioid receptor agonists and cannabinoid receptor agonists (full–2014) http://jpet.aspetjournals.org/content/early/2014/09/05/jpet.114.216648.long
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol / high fat diet induced pancreatitis (full–2014) http://www.molecularpain.com/content/10/1/66
NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors (full–2014) http://www.molecularpain.com/content/pdf/1744-8069-10-77.pdf
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (full–2014) http://www.mdpi.com/1422-0067/15/8/13637/htm
Therapeutic Potential of Inhibitors of Endocannabinoid Degradation for the Treatment of Stress-Related Hyperalgesia in an Animal Model of Chronic Pain (full–2014)
http://www.nature.com/npp/journal/v40/n2/full/npp2014198a.html
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201700/
CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288820/
Effects of the fatty acid amide hydrolase inhibitor URB597 on pain-stimulated and paindepressed behavior in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963812/
TRP channel cannabinoid receptors in skin sensation, homeostasis, and inflammation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240254/
Complementary and alternative medical therapies in multiple sclerosis-the american academy of neurology guidelines: a commentary (full–2014)
http://www.clinicaltherapeutics.com/article/S0149-2918%2814%2900684-5/fulltext
Use of a Synthetic Cannabinoid in a Correctional Population for Posttraumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications: A Retrospective Evaluation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165471/
A lipid gate for the peripheral control of pain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228127/
Endocannabinoid system and pain: an introduction (full–2014) http://journals.cambridge.org/download.php?file=%2FPNS%2FPNS73_01%2FS0029665113003650a.pdf&code=d63f269fd26979b3968140bc4db80943
Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12488/full
The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2014) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
Acute Resistance Exercise Induces Antinociception by Activation of the Endo-cannabinoid System in Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139418/
Sex differences in antinociceptive tolerance to delta-9-tetrahydrocannabinol in the rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161674/
Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid-like fatty acid amides (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12272/full
Toward modulation of the endocannabinoid system for treatment of gastrointestinal disease: FAAHster but not “higher” (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12329/full
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274248/
Mechanisms of Exercise-Induced Hypoalgesia (full–2014)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302052/
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206939/
Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ-Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain (full–2014) http://jpet.aspetjournals.org/content/351/1/224.long
Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294036/
Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626020/
The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: Neuronal KATP channel opening and CB1 receptor activation (full–2014) http://www.sciencedirect.com/science/article/pii/S0014299914005561
top
Effects of Two Different Specific Neck Exercise Interventions on Palmitoylethanolamide and Stearoylethanolamide Concentrations in the Interstitium of the Trapezius Muscle in Women with Chronic Neck Shoulder Pain (full–2014) http://painmedicine.oxfordjournals.org/content/15/8/1379.long
Attenuation of Cystitis and Pain Sensation in Mice Lacking Fatty Acid Amide Hydrolase. (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4355044/
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844071/
The Medicinal Cannabis Treatment Agreement: Providing Information to Chronic Pain Patients via a Written Document (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4417655/
The Neurobiology of Cancer Pain (abst–2014) http://nro.sagepub.com/content/early/2014/03/24/1073858414525828.abstract
Intraganglionic injection of a nitric oxide donator induces afferent mechanical sensitization that is attenuated by palmitoylethanolamide (abst–2014) http://cep.sagepub.com/content/34/9/686.abstract
Cannabinoid Receptor Type 1 Antagonist, AM251, Attenuates Mechanical Allodynia and Thermal Hyperalgesia after Burn Injury (link to PDF–2014) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1936541&resultClick=3
The Comprehensive Report on the Cannabis Extract Movement and the Use of Cannabis Extracts to Treat Diseases (link to download-2014) http://www.slideshare.net/TheHempSolution/comprehensive-report-on-the-cannabis-extract-movement
Report on Medical Cannabis Research History- What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
The oral administration of trans-caryophyllene attenuates acute and chronic pain in mice (abst–2014) http://www.sciencedirect.com/science/article/pii/S0944711313003097
Peripheral neurobiologic mechanisms of antiallodynic effect of warm water immersion therapy on persistent inflammatory pain full–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23461/full
Involvement of the endocannabinoid system in osteoarthritis pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494687
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/ptr.5265/full
Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494683
Neurotrophins, endocannabinoids and thermo-transient receptor potential: a threesome in pain signalling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494676
Anandamide in primary sensory neurons: too much of a good thing? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494681
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
Inhibition of Voltage-Gated Na+ Channels by the Synthetic Cannabinoid Ajulemic Acid (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24755846
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24813296
Dronabinol and chronic pain: importance of mechanistic considerations (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24819592
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24906199
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24951841
Analgesic tolerance and cross-tolerance to the cannabinoid receptors ligands hemopressin, VD-hemopressin(α) and WIN55,212-2 at the supraspinal level in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25010019
Effects of opioids and cannabinoids during chronic morphine treatment in rhesus monkeys (abst–2014) http://www.fasebj.org/content/28/1_Supplement/658.3.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102
Arsenic decreases antinociceptive activity of paracetamol: Possible involvement of sero-tonergic and endocannabinoid receptors (abst–2014)
top
Fibromyalgia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24365316
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25150831
Cannabidiol and endogenous opioid peptide-mediated mechanisms modulate anti-nociception induced by transcutaneous electrostimulation of the peripheral nervous system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25282545
Colitis generates remote antinociception in rats: the role of the Larginine/NO/cGMP/ PKG/KATP pathway and involvement of cannabinoid and opioid systems (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25286904
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Evaluation of the tolerability and efficacy of Sativex in multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25331416
Interaction of a Cannabinoid-2 Agonist With Tramadol on Nociceptive Thresholds and Immune Responses in a Rat Model of Incisional Pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25370921
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446925
Diacerein is a potent and selective inhibitor of palmitoylethanolamide inactivation with analgesic activity in a rat model of acute inflammatory pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25447594
Involvement of the endocannabinoid system in attentional modulation of nociceptive behaviour in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25504741
Potential applications of marijuana and cannabinoids in medicine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Experience of adjunctive cannabis use for chronic non-cancer pain: Findings from the Pain and Opioids IN Treatment (POINT) study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25533893
Re-branding cannabis: the next generation of chronic pain medicine? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25537695
Endocannabinoids and their oxygenation by cyclo-oxygenases, lipoxygenases and other oxygenases (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25543004
Distinct interactions of cannabidiol and morphine in three nociceptive behavioral models in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25485642
Cannabis use provides symptom relief in patients with inflammatory bowel disease but is associated with worse disease prognosis in patients with Crohn’s disease (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/24407485
Selective monoacylglycerol lipase inhibitors: Antinociceptive vs. cannabimimetic effects in mice (full–2015) http://jpet.aspetjournals.org/content/early/2015/03/11/jpet.114.222315.long
The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Peri-aqueduactal Grey (full–2015) http://molpharm.aspetjournals.org/content/early/2015/05/12/mol.115.099333.long
Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice (full–2015) http://jpet.aspetjournals.org/content/354/2/111.full
Use of Prescription Pain Medications Among Medical Cannabis Patients: Comparisons of Pain Levels, Functioning, and Patterns of Alcohol and Other Drug Use (full–2015) http://ssw.umich.edu/sites/default/files/documents/news/use-of-prescription-pain-medications-amongmedical-cannabis-patients.pdf
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446380/
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25560837
Selective blockade of the hydrolysis of the endocannabinoid 2-arachidonoylglycerol impairs learning and memory performance while producing antinociceptive activity in rodents (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4284516/
Coadministration of indomethacin and minocycline attenuates established paclitaxel induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors (full–2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25553163
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
Cannabis and Cannabinoids–for health professionals (PDQ®) (full–2015)
http://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq#section/all
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2015) http://www.ncbi.nlm.nih.gov/books/NBK65875/
High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/09/04/ijnp.pyv095.long
top
The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002286
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec (full–2015) http://cmajopen.ca/content/3/2/E251.full?sid=139f05c1-b441-476b-99ff-addf8c918e1a
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid / N-acylethanolamine-dependent mechanisms (full–2015) http://molecularpain.biomedcentral.com/articles/10.1186/s12990-015-0056-8
TRPV1 channel inhibition contributes to the antinociceptive effects of Croton macrostachyus extract in mice (full–2015) http://bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-015-0816-z
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015) http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Systematic Review of the Use of Phytochemicals for Management of Pain in Cancer Therapy (full–2015) http://www.hindawi.com/journals/bmri/2015/506327/
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25849525
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis (full-2015) http://onlinelibrary.wiley.com/doi/10.1111/cns.12349/full
Cannabinoids for Medical Use: A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec (full–2015) http://cmajopen.ca/content/3/2/E251.full?sid=139f05c1-b441-476b-99ff-addf8c918e1a
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway Underlies Altered Pain Perception in Leptin Signalling Deficiency (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26081302
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway
Underlies Altered Pain Perception in Leptin Signalling Deficiency (full–2015) http://www.nature.com/npp/journal/v41/n2/full/npp2015173a.html
Endocannabinoids and acute pain after total knee arthroplasty (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25599456
Endocannabinoids and acute pain after total knee arthroplasty (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299927/
Cannabinoids in the management of chronic pain: a front line clinical perspective (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0059/jbcpp-2015-0059.xml
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26067584
Patterns of Use of Medical Cannabis Among Israeli Cancer Patients: A Single Institution Experience (full–2015) http://www.jpsmjournal.com/article/S0885-3924(14)00312-1/fulltext
Gonadal hormones do not alter the development of antinociceptive tolerance to delta-9-tetrahydrocannabinol in adult rats (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25863271
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (full–2015) http://jama.jamanetwork.com/article.aspx? articleid=2338266
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338230
Sequelae of Cannabis as Medicine (full–2015) http://painmedicine.oxfordjournals.org/content/16/7/1447
Anandamide Depresses Glycinergic and GABAergic Inhibitory Transmissions in Adult Rat Substantia Gelatinosa Neurons (full–2015) http://file.scirp.org/Html/1-2500613_54452.htm
Use of paracetamol during pregnancy and child neurological development (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25851072
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843054
Fatty acid amide hydrolase inhibitors: a patent review (2009-2014) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26413912
Clinical perspectives on medical marijuana (cannabis) for neurologic disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549715/
The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26512068
The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat (full–2015) http://journals.sagepub.com/doi/full/10.1177/0333102415613766
Diet-induced changes in n-3 and n-6 derived endocannabinoids and reductions in headache pain and psychological distress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958314
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation : a case report (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26507533
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation: a case report (abst–2015) http://link.springer.com/article/10.1007/s12630-015-0525-6
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25869205
The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension-induced visceral pain models in Rodents (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/nmo.12563/full
The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26374993
The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats. (link to download–2015) http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=4378&category_id=119&option=com_virtue mart&vmcchk=1&Itemid=1
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (full–2015) http://www.cps.org.tw/files/201503160252300.pdf
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (click “Full Text Links” for PDF-2015) http://www.ncbi.nlm.nih.gov/pubmed/25687494
Cannabis for the Management of Pain: Assessment of Safety Study (COMPASS) (link to PDF–2015) http://www.jpain.org/article/S1526-5900%2815%2900837-8/abstract
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation (link to PDF–2015) http://www.haematologica.org/content/early/2015/12/21/haematol.2015.136523.long
Acupuncture Mechanisms: Anesthesia, Analgesia and Protection on Organ Functions (link to PDF–2015) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.732.8262&rank=2&q=cannabinoid&osm=&ossid
Veterans Health Administration Policy on Cannabis as an Adjunct to Pain Treatment with Opiates (article–2015) http://journalofethics.ama-assn.org/2015/06/pfor2-1506.html
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25796592
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic Review of Randomized Controlled Trials (full–2015) http://tinyurl.com/ojn89dh
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuro-pathic Pain: A Systematic Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25635955
Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25656689
Peripherally Restricted Cannabinoids for the Treatment of Pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497478
Profiles of medicinal cannabis patients attending compassion centers in rhode island (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715068
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Cannabinoid CB1 receptors mediate the effects of dipyrone (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25430877
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
top
The role of the endocannabinoid system in pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25846617
Emerging concepts of pain therapy based on neuronal mechanisms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25846611
Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25988529
Lipid nanoparticles as an emerging platform for cannabinoid delivery: physicochemical optimization and biocompatibility (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25996463
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26126926
Retrospective Analysis of Tetrahydrocannabinol Based on 31 Neurologically Critically Ill Children (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1550707
Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26202613
Microinjection of orexin-A into the rat locus coeruleus nucleus induces analgesia via cannabinoid type-1 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26254729
Clinical pharmacology of medical cannabinoids in chronic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26267945
Neuropeptide VF Enhances Cannabinoid Agonist WIN55,212-2-Induced Antinociception in Mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26273748
A 4-Week Pilot Study With the Cannabinoid Receptor Agonist Dronabinol and Its Effect
on Metabolic Parameters in a Randomized Trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26283236
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408049
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26465930
A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26486424
Brain Mapping-Based Model of Δ9-Tetrahydrocannabinol Effects on Connectivity in the Pain Matrix (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26514581
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26520391
The long-term functional consequences of acute infectious diarrhea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26628101
The Role of the Brain’s Endocannabinoid System in Pain and Its Modulation by Stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638768
Use of Cannabinoids for Spasticity and Pain Management in MS (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26705757
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26720619
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25557763
top
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206340
Combined Treatment with Morphine and Δ9-Tetrahydrocannibinol (THC) in Rhesus Monkeys: Antinociceptive Tolerance and Withdrawal (abst–2015) http://www.fasebj.org/content/29/1_Supplement/616.9.abstract?sid=edf921ac-0690-4aa6-ac81- 0546314dd384
β-caryophyllene-complexed in β-cyclodextrin Produces Antihyperalgesic Activity in Animal Model for Fibromyalgia (abst–2015) http://www.fasebj.org/content/29/1_Supplement/616.4.abstract?sid=edf921ac-0690-4aa6-ac81- 0546314dd384
Efficacy and safety of nabiximols (Sativex®) on multiple sclerosis spasticity in a real-life Italian monocentric study (abst–2015) http://link.springer.com/article/10.1007/s10072-015-2392-x
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord (abst–2015) http://link.springer.com/article/10.1007/s10753-015-0168-3
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://link.springer.com/article/10.1007/s11916-015-0524-x
Is cannabis use associated with less opioid use among people who inject drugs? (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2900250-1/abstract
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2 (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=7042&path%5B%5D=20008
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing Remitting Multiple Sclerosis (full–2016) http://link.springer.com/article/10.1007/s13311-016-0420-z/fulltext.html
δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats (full–2016) http://www.mdpi.com/2072-6651/8/4/106/htm
A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase (full–2016) http://mpx.sagepub.com/content/12/1744806916649192.long
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity (full–2016) http://mpx.sagepub.com/content/12/1744806916649191.long
Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice (full–2016) http://jpet.aspetjournals.org/content/early/2016/05/26/jpet.116.232132.long
Interactions between cannabinoid receptor agonists and mu opioid receptor agonists in rhesus monkeys discriminating fentanyl (full–2016) http://www.sciencedirect.com/science/article/pii/S0014299916303235
Chest pain, troponin rise, and ST-elevation in an adolescent boy following the use of the synthetic cannabis product K2 (full–2016) http://www.annalspc.com/article.asp?issn=0974- 2069;year=2016;volume=9;issue=1;spage=79;epage=81;aulast=Zaleta
Cannabinoid pharmacology in cancer research: A new hope for cancer patients? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791144/
Expression of the endocannabinoid receptors in human fascial tissue (full–2016) http://www.ejh.it/index.php/ejh/article/view/2643/2590
Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00257/full
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00304/full
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines (full–2016) https://www.ncbi.nlm.nih.gov/books/NBK395789/
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0167965
Paracetamol sharpens reflection and spatial memory: a double-blind randomized controlled study in healthy volunteers (full–2016) https://www.dovepress.com/paracetamol-sharpens-reflection-and-spatial-memory-a-double-blind-randpeer-reviewed-article-DDDT
Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719019/ Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis (full–2016) http://journals.sagepub.com/doi/full/10.1177/1933719116630414
A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems (full–2016) https://jvat.biomedcentral.com/articles/10.1186/s40409-016-0091-6
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/ Cannabis and Cannabinoids (PDQ®)Health Professional Version (full–2016) https://www.ncbi.nlm.nih.gov/books/NBK65755/
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy (full–2016) https://www.hindawi.com/journals/pd/2016/1279042/
Dissecting the signaling pathways involved in the crosstalk between mGlu5 and CB1 receptors (link to PDF–2016) http://molpharm.aspetjournals.org/content/early/2016/06/23/mol.116.104372.long
Endocannabinoid system: Role in depression, reward and pain control (Review) (link to PDF–2016) https://www.spandidos-publications.com/10.3892/mmr.2016.5585
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis (link to full via ELSEVIER–2016) http://www.ncbi.nlm.nih.gov/pubmed/27133395
Behavioral Characterization of Kappa Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats (link to download–2016) http://jpet.aspetjournals.org/content/early/2016/11/30/jpet.116.235630.long
Using Medical Cannabis in an Oncology Practice (article–2016) (needs free registration) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Using Medical Cannabis in an Oncology Practice (1st page–2016) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.dpuf
Opioids Out, Cannabis In (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2576617
Cannabis and Cannabinoids. (1st page–2016) http://jamanetwork.com/journals/jama/article-abstract/2592497
Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26762784
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
top
Effect of JWH-250, JWH-073 and their interaction on “tetrad”, sensorimotor, neuro-logical and neurochemical responses in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26780169
Quantification of pain in sickle mice using facial expressions and body measurements (abst–2016) http://www.sciencedirect.com/science/article/pii/S1079979615300218
CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens (abst–2016) http://link.springer.com/article/10.1007/s12031-016-0716-9
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809974
RGS proteins as targets in the treatment of intestinal inflammation and visceral pain: New insights and future perspectives (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26817719
Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26808012
Dronabinol increases pain threshold in patients with functional chest pain: a pilot doubleblind placebo-controlled trial (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26822791
Medical cannabis: considerations for the anesthesiologist and pain physician (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26850063
β-caryophyllene, a dietary cannabinoid, complexed with β-cyclodextrin produced antihyperalgesic effect involving the inhibition of Fos expression in superficial dorsal horn (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26883973
Development and Pharmacological Characterization of Selective Blockers of 2- Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01812
Stress induces analgesia via orexin 1 receptor-initiated endocannabinoid/CB1 signaling in the mouse periaqueductal gray (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300545
Cannabinoids: Medical implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26912385
Nabilone for the Management of Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26923810
A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935064
Role of cannabinoids in gastrointestinal mucosal defense and inflammation (abst–2016) http://www.eurekaselect.com/140045/article
Combined treatment with morphine and Δ9-tetrahydrocannibinol (THC) in rhesus monkeys: antinociceptive tolerance and withdrawal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26937020
Effects of cannabinoid receptor activation by CP55,940 on normal bladder function and irritation-induced bladder overactivity in non-awake anaesthetised rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26942594
Sickle Cell Crisis Complicated by Synthetic Cannabinoid Abuse: A Case Report (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26956672
Cannabis in Pain Treatment: Clinical & Research Considerations (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26961090
The Effect of Medicinal Cannabis on Pain and Quality of Life Outcomes in Chronic Pain: A Prospective Open-label Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26889611
Rational Basis for the Use of Bergamot Essential Oil in Complementary Medicine to Treat Chronic Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26996621
Medical cannabis associated with decreased opiate medication use in retrospective crosssectional survey of chronic pain patients (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27001005
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028159
Piperidinyl thiazole isoxazolines: A new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties (abst–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16301834
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27157075
Pain, Cannabis Species, and Cannabis Use Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27172585
MEDICAL CANNABIS (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215115
Differences in Chloride Gradients Allow for Three Distinct Types of Synaptic Modulation by Endocannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27226449
TRPV1-FAAH-COX: The Couples Game in Pain Treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27240888
Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: a systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27267445
Transmission Pathways and Mediators as the Basis for Clinical Pharmacology of Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27322358
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667
PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase (abst–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13448/abstract
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27286745
Problematic Use of Prescription Opioids and Medicinal Cannabis Among Patients Suffering from Chronic Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27346885
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27349158
Changes in nociceptin/orphanin FQ levels in rat brain regions after acute and chronic cannabinoid treatment in conjunction with the development of antinociceptive tolerance (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27371029
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis (abst–2016) http://www.msard-journal.com/article/S2211-0348(16)30056-6/abstract
Peripheral interactions between cannabinoid and opioid receptor agonists in a model of inflammatory mechanical hyperalgesia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450703
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Endocannabinoids control vesicle release mode at midbrain periaqueductal grey inhibitory synapses (abst–2016) http://onlinelibrary.wiley.com/doi/10.1113/JP272292/abstract
The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27504865
Robust anti-nociceptive effects of MAG lipase inhibition in a model of osteoarthritis pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27501482
Sex-dependent effects of cannabis-induced analgesia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27522535
Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114016300913
Peltatoside Isolated from Annona crassiflora Induces Peripheral Antinociception by Activation of the Cannabinoid System (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/27574895
Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27589093
Pain in Extrapyramidal Neurodegenerative Diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623111
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27649266
Gonadal hormone modulation of ∆9-tetrahydrocannabinol-induced antinociception and metabolism in female versus male rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716301599
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26809974
Nature of the placebo and nocebo effect in relation to functional neurologic disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719874
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson’s disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27723182 Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools (abst–2016) http://www.eurekaselect.com/146167/article
Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and Nacylethanolamine acid amidase inhibitors (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00538
Role of cannabis in digestive disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Medical Marijuana: Just the Beginning of a Long, Strange Trip? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27660328
Cannabinoids in the Management of Musculoskeletal or Rheumatic Diseases (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27832442
Antagonism of cannabinoid receptor 1 attenuates the anti-inflammatory effects of electroacupuncture in a rodent model of migraine (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27834685
Cannabinoid receptor ligand bias: implications in the central nervous system (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27835801
The central cannabinoid receptor type-2 (CB2) and chronic pain (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842450
State of the evidence: Cannabinoids and cancer pain-A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27863159
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305123
A novel inhibitor of endocannabinoid catabolic enzymes sheds light on behind the scene interplay between chronic pain, analgesic tolerance, and heroin dependence (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305226
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478
Pain in amyotrophic lateral sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27964824
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997038
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28040884
Cannabis use in persons with traumatic spinal cord injury in Denmark (link to PDF-2017) https://www.medicaljournals.se/jrm/content/abstract/10.2340/16501977-2105
Medical Cannabis in the Palliation of Malignant Wounds—A Case Report (article–2017) http://www.jpsmjournal.com/article/S0885-3924(16)30328-1/abstract
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28100744
Role of cannabis in digestive disorders (abst–2017) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10 &index=3
Antihyperalgesic effect of CB1 receptor activation involves the modulation of P2X3 receptor in the primary afferent neuron (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131783


PANCREAS/PANCREATITIS
Expression and function of cannabinoid receptors in mouse islets (full–2010) http/www.landesbioscience.com/journals/islets/LiISLETS2-5.pdf
Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells (full–2010) http/www.karger.com/Article/Pdf/320527
Cannabinoid agonist WIN55,212 in vitro inhibits interleukin-6 (IL-6) and monocyte chemo-attractant protein-1 (MCP-1) release by rat pancreatic acini and in vivo induces dual effects on the course of acute pancreatitis (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2010.01569.x/full
G1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion (link to PDF–2010) http/www.europeanreview.org/article/724
The role of small molecule GPR119 agonist, AS1535907, in glucose-stimulated insulin secretion and pancreatic β-cell function (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/21114601
Cannabinoids inhibit insulin receptor signaling in pancreatic β-cells (full–2011) http/www.ncbi.nlm.nih.gov/pubmed/21346174
Gut feelings about the endocannabinoid system (full–2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01689.x/full
top
The role of the endocannabinoid system in islet biology (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21311323
The CB-1 Receptor Antagonist Rimonabant Modulates the Interaction Between Adipocytes and Pancreatic Beta-Cells in Vitro (abst–2011) https/www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1261963
Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis (full–2012) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0052921
Activation of Cannabinoid Receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms (full–2012) http/ajpgi.physiology.org/content/304/2/G181
Expression and function of monoacylglycerol lipase in mouse β-cells and human islets of Langerhans (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22739267
Islet protection and amelioration of diabetes type 2 in Psammomys obesus by treatment with cannabidiol (link to PDF–2012) http/www.scirp.org/searchResult/Index.aspx?searchCode=Islet+protection+and+amelioration+of+diabetes+type+2+in+Psammomys+obesus+by+treatment+with+cannabidiol
Effects of CP 55,940–agonist of CB1 cannabinoid receptors on ghrelin and somatostatin producing cells in the rat pancreas (full–2012) http/czasopisma.viamedica.pl/fhc/article/view/18705/14714
Cannabis exposure associated with weight reduction and β-cell protection in an obese rat model (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22421529
Honokiol attenuates the severity of acute pancreatitis and associated lung injury via acceleration of acinar cell apoptosis (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22258232
Cannabinoid HU210 Protects Isolated Rat Stomach against Impairment Caused by Serum of Rats with Experimental Acute Pancreatitis (full–2013) http/www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0052921
Islet cannabinoid receptors: cellular distribution and biological function (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24005231
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/22850623
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol / high fat diet induced pancreatitis (full–2014) http://www.molecularpain.com/content/10/1/66
A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161845/
top
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β-cells health and function (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083038/
A Role for Trans-caryophyllene in the Moderation of Insulin Secretion (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24486541
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ9 -THC (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25187240
Role of the endocannabinoid system in obesity induced by neuropeptide Y overexpression in noradrenergic neurons (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423197/
Cannabinoid CB1 receptors and mTORC1 signalling pathway interact to modulate glucose homeostasis (full–2015) http://dmm.biologists.org/content/9/1/51.long
Role of the Endocannabinoid System in Diabetes and Diabetic Complications (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13226/full
Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653226/
Food Liking Enhances the Plasma Response of 2-Arachidonoylglycerol and of Pancreatic Polypeptide upon Modified Sham Feeding in Humans (full–2015) http://jn.nutrition.org/content/145/9/2169.long
Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150981 Endocannabinoid regulation of β-cell functions: Implications for glycemic control and diabetes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045244/
Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949433/
β-Caryophyllene, a natural sesquiterpene lactone attenuates hyperglycemia mediated oxidative and inflammatory stress in experimental diabetic rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S000927971530154X
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26809974
GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561953
Efficacy and Safety of Cannabidiol and Tetrahydrocannabivarin on Glycemic and Lipid Parameters in Patients With Type 2 Diabetes: A Randomized, Double-Blind, PlaceboControlled, Parallel Group Pilot Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27573936
Efficacy, tolerability, and safety of cannabinoids in gastroenterology: A systematic review (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26809974
Experimental cannabidiol treatment reduces early pancreatic inflammation in type 1 diabetes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27767974
Role of cannabis in digestive disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes (abst–2017) http://diabetes.diabetesjournals.org/content/early/2017/01/11/db16-1199.long


PARKINSON’S DISEASE
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders (full–2010) http:// onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00144.x/full
Enhancement of endocannabinoid signaling by fatty acid amide hydrolase inhibition: a neuroprotective therapeutic modality (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2848893/?tool=pubmed
Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson’s disease in the rat (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659808/
Cannabinoids and Dementia: A Review of Clinical and Preclinical Data (link to PDF–2010) http://www.mdpi.com/1424-8247/3/8/2689
The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20888328
In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson’s disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20026090
top
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?tool=pubmed
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Prospects for cannabinoid therapies in basal ganglia disorders (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165947/
Symptom-relieving and neuroprotective effects of the phytocannabinoid D(9) -THCV in animal models of Parkinson’s disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165958/pdf/bph0163-1495.pdf
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full–2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuro-inflammation (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249428/
Therapeutic Potential of Cannabinoids in the Treatment of Neuroinflammation Associated with Parkinson’s Disease (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21568925/abstract/Therapeutic_Potential_of_Cannabinoids_in_the_Treatment_of_Neuroinflammation_Associated_with_Parkinson%27s_Disease_
Regional changes in type 1 cannabinoid receptor availability in Parkinson’s disease in vivo (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21459482/abstract/Regional_changes_in_type_1_cannabinoid_receptor_availability_in_Parkinson%27s_disease_in_vivo_
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20862500
Homeostatic changes of the endocannabinoid system in Parkinson’s disease (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21412829/abstract/Homeostatic_changes_of_the_endocannabinoid_system_in_Parkinson%27s_disease_
Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors (abst–2011) http://www.neurobiologyofaging.org/article/S0197-4580%2809%2900116-X/abstract
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full
top
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Cannabinoid modulation of neuroinflammatory disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273613/
Cannabinoids and value-based decision making: implications for neurodegenerative disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496267/
The decrease of dopamine D(2)/D(3) receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB(1) cannabinoid receptors in Parkinson’s disease: A preliminary autoradiographic study with the selective dopamine D(2)/D(3) antagonist [(3)H]raclopride and the novel CB(1) inverse agonist
[(125)I]SD7015 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180092/
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Δ(9)-THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22236282
Contribution of genetic variants to pain susceptibility in Parkinson disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22473870
Contribution of genetic variants to pain susceptibility in Parkinson disease (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/j.1532-2149.2012.00134.x/abstract
Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730975/
Striatal Molecular Signature of Subchronic Subthalamic Nucleus High Frequency Stimulation in Parkinsonian Rat (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617149/
Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats (full–2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076874
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
top
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptors activation in mice (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584613001164
A spontaneous deletion of α-Synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: Effects on alcohol consumption (abst–2013) http://onlinelibrary.wiley.com/doi/10.1002/syn.21639/abstract
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy (full–2013) http://iospress.metapress.com/content/4j61942x88175321/fulltext.html
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829360
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial biogenesis in a cell culture model of Parkinson’s Disease (abst–2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24140894
The combination of oral L-DOPA/rimonabant for effective dyskinesia treatment and cytological preservation in a rat model of Parkinson’s disease and L-DOPA-induced dyskinesia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24196024
L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24230991
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226453/
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDA-lesioned rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323744/
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25237116
Report on Medical Cannabis Research, What the Science Says (article–2014) http://www.safeaccessnow.org/medical_cannabis_research_what_does_the_evidence_say
L-DOPA disrupts adenosine A2A-cannabinoid CB1-dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24412491
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuro-protection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24599755
Cannabis (Medical Marijuana) Treatment for Motor and Non-Motor Symptoms of Parkinson Disease: An Open-Label Observational Study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24614667
top
Cannabidiol can improve complex sleep-related behaviours associated with rapid eye movement sleep behaviour disorder in Parkinson’s disease patients: a case series (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24845114
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24973119
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25481767
Self-Reported Efficacy of Cannabis and Other Complementary Medicine Modalities by Parkinson’s Disease Patients in Colorado (full–2015) http://www.hindawi.com/journals/ecam/2015/874849/
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection (full–2015) http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2901163-8
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26244281
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (full-2015) http://www.sciencedirect.com/science/article/pii/S0014488615300583
The therapeutic potential of cannabinoids for movement disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25649017
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on Mesocorticolimbic Dopamine Function (full–2015) http://www.sciencedirect.com/science/article/pii/S007477421500135X
Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26059564
Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26152606
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26260390
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism (link to PDF–2015) http://link.springer.com/article/10.1007/s00429-014-0823-8
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
The role of cannabinoids and leptin in neurological diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25880465
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25895887
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB 2 Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25976369
top
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Cannabinoids for the Treatment of Movement Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206230
Endocannabinoids and Neurodegenerative Disorders: Parkinson’s Disease, Huntington’s Chorea, Alzheimer’s Disease, and Others (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408163
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301441
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis and might be relevant to Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0887233315300047
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10314&path%5B%5D=32486
Cannabidiol Prevents Motor and Cognitive Impairments Induced by Reserpine in Rats (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00343/full
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Marijuana Compounds: A Nonconventional Approach to Parkinson’s Disease Therapy (full–2016) https://www.hindawi.com/journals/pd/2016/1279042/
Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816302663
Reversal effect of simvastatin on the decrease in cannabinoid receptor 1 density in 6- hydroxydopamine lesioned rat brains (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27155397
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinsons disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27318096
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373318
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action (abst–2016) https://www.researchgate.net/publication/304669756_Coadministration_of_cannabidiol_and_capsazepine_ reduces_L-DOPA-induced_dyskinesia_in_mice_Possible_mechanism_of_action
Type-2 cannabinoid receptors in neurodegeneration (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Nature of the placebo and nocebo effect in relation to functional neurologic disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719874
Effect of medical cannabis on thermal quantitative measurements of pain in patients with Parkinson’s disease (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27723182
Pros and cons of medical cannabis use by people with chronic brain disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27804883
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104279
top


PATENTS RELATED TO CANNABIS
US Patent 7674922 B2 Process for production of delta-9-tetrahydrocannabinol (full–2010) http/www.google.com/patents/US7674922
NEW USE FOR CANNABINOID-CONTAINING PLANT EXTRACTS Patent application number: 20100249223 (full–2010) http/www.faqs.org/patents/app/20100249223
CANNABINOID-CONTAINING PLANT EXTRACTS AS NEUROPROTECTIVE AGENTS Patent application number: 20100239693 (full–2010) http/www.faqs.org/patents/app/20100239693
Patent application title: PHARMACOLOGICAL TREATMENT OF PSORIASIS (full–2010) http/www.faqs.org/patents/app/20080255224
US Patent Application 20100012118 – Medicament dosage for inhaler (full–2010) http/www.freepatentsonline.com/y2010/0012118.html
Patent 7741365 Peripheral cannabinoid receptor (CB2) selective ligands (full–2010) http/www.freepatentsonline.com/7741365.html
Patent 7816143 Oral detection test for cannabinoid use (full–2010) http/www.freepatentsonline.com/7816143.pdf
US Patent Application 20100204312 – METHODS AND COMPOSITIONS FOR TREATING CANCER (full–2010) https/www.google.com/patents/US20100204312
Patent TW201002315 (A) ― 2010-01-16 Anti-tumoural effects of cannabinoid combinations (full–2010) http/worldwide.espacenet.com/publicationDetails/description?CC=TW&NR=201002315A&KC=A&FT&ND=3&date=20100116&DB=EPODOC&locale=en_EP
US Patent Application 20100158973 – THERAPEUTIC USES OF CANNABIDIOL COMPOUNDS (full–2010) http/www.google.com/patents/US20100158973
CONTROLLED-RELEASE APOPTOSIS MODULATING COMPOSITIONS AND METHODS FOR THE TREATMENT OF OTIC DISORDERS Patent application number: 20100016218 (full–2010) http/www.faqs.org/patents/app/20100016218
European Patent Application EP2044935- A composition containing non-psychotropic cannabinoids for the treatment of inflammatory diseases (full–2010) http/www.freepatentsonline.com/EP2044935A1.html
Medicinal Acidic Cannabinoids US Patent 7807711B2 (full–2010) http/www.cannabisinternational.org/info/Medicinal-Acidic-Cannabinoids.pdf
US Patent Application 20110097283 – CHEWING GUM COMPOSITIONS COMPRISING CANNABINOIDS (full–2011) http/www.google.com/patents/US20110097283
US Patent 7884133 B2 Cannabidiol derivatives such as 3-(2,6-dihydroxy-4-pentyl-phenyl)-4-prop-1-en-2-ylcyclohexene-1-carboxylic acid, used as as analgesics, anti-inflammatory and anti-diarrheal agents (full–2011) https/www.google.com/patents/US7884133?dqatent+7884133&hl=en&sa=X&ei=Ujb0U_6EEIW5ogSl84LYDg&ved=0CB4Q6AEwAA
US Patent Application 20110052694 – USE OF CANNABIDIOL PRODRUGS IN TOPICAL AND TRANSDERMAL ADMINISTRATION WITH MICRONEEDLES (full–2011) http/www.google.com/patents/US20110052694
US Patent EP 2560512 A1 – Smoke and Odor Elimination Filters, Devices and Methods (full–2011) http/www.google.com/patents/EP2560512A1?cl=en
US Patent Application 20110020945 – ORAL DETECTION TEST FOR CANNABINOID USE (full–2011) http/www.freshpatents.com/-dt20110127ptan20110020945.php
US Patent Application 20110082195 – NEW USE FOR CANNABINOIDS (full–2011) http/www.faqs.org/patents/app/20110082195
Patent GB2478595 (A)―2011-09-14 Phytocannabinoids for use in the treatment of cancer (full–2011) http/worldwide.espacenet.com/publicationDetails/biblio?CC=GB&NR=2478595A&KC=A&FT&ND=&date=20110914&DB=&locale=en_EP
Patent US2012052119 (A1)―2012-03-01 NANOENCAPSULATED DELTA-9-TETRAHYDROCANNABINOL (full–2012) http/worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012052119A1&KC=A1&FT&ND=3&date=20120301&DB=EPODOC&locale=en_EP
Controlled cannabis decarboxylation – Patent US2012046352 (A1)―2012-02-23 (full–2012) http/worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012046352A1&KC=A1&FT&ND=3&date=20120223&DB=EPODOC&locale=en_EP
top
TRANSDERMAL DELIVERY OF CANNABINOIDS – Patent US2012034293 (A1)―2012-02-09 (full–2012) http/worldwide.espacenet.com/publicationDetails/description?CC=US&NR=2012034293A1&KC=A1&FT&ND=3&date=20120209&DB=EPODOC&locale=en_EP
Use of the phytocannabinoid cannabidivarin (cbdv) in the treatment of epilepsy: Patent Application 20120004251 (full–2012) http/www.freshpatents.com/-dt20120105ptan20120004251.php
US Patent 8106244 B2 Process for production of delta-9-tetrahydrocannabinol (full–2012) http/www.google.com/patents/US8106244
Topical Compositions with Cannabis Extracts United States Patent Application 20120264818 (full–2012) http/www.freepatentsonline.com/y2012/0264818.html
US Patent Application 20130251824 – Recycling cannabinoid extractor (full–2013) http/www.faqs.org/patents/app/20130251824
US Patent Application 20130245110 – USE FOR CANNABINOIDS (CBD/ THCV for cholesterol control) (full–2013) http/www.freepatentsonline.com/y2013/0245110.html
Transdermal delivery of cannabidiol Patent 8435556 (full–2013) https/www.google.com/patents/US8435556
US Patent Application 20130280343 – Food Products Derived From Cannabinoid-Administered Livestock (full–2013) http/www.freepatentsonline.com/y2013/0280343.html
US Patent Application 20130171145 – METHODS OF TREATING LIVER DISEASE (full–2013) http/www.freepatentsonline.com/y2013/0171145.html
US Patent Application 20130059018 – PHYTOCANNABINOIDS IN THE TREATMENT OF CANCER (full–2013) http/www.google.com/patents/US20130059018
USE FOR CANNABINOIDS (Patent Cholesterol I or II diabetes, obesity, dyslipidaemia, related metabolic disorders and cardiovascular disease -2013) (full–2013) http://www.faqs.org/patents/app/20130245110
Anti-tumoural effects of cannabinoid combinations – US 8632825 B2 (full–2014) https://www.google.com/patents/US8632825?dq=patent+cannabinoid&hl=en&sa=X&ei=M1DyU6KwDYHcOuy6gLgF&ved=0CDMQ6AEwAw
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215781
Cannabimimetic Drugs: Recent Patents in Central Nervous System Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334611


PERINATAL ASPHYXIA
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide / endocannabinoid signaling system associated to memory impairments in postweaned rats (full–2015) http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/100/6/F541.full.pdf+html
top


PERINATAL HYPOXIC-ISCHEMIC INJURY
Synergistic neuroprotective therapies with hypothermia (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892736/?tool=pubmed
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia (full–2010) http://stroke.ahajournals.org/content/41/12/2956.long
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic ischemic brain damage in mice is mediated by CB(2) and adenosine receptors (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19900555
Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia ischemia in newborn pigs (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21654550
The Cannabinoid WIN 55212-2 Mitigates Apoptosis and Mitochondrial Dysfunction After Hypoxia Ischemia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21909954
Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21788999
Therapeutic potential of the endocannabinoid system in perinatal asphyxia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22127663
Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446851/
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22659086
Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22841538
Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic ischemic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23587650
Mitochondrial JNK phosphorylation as a novel therapeutic target to inhibit neuro-inflammation and apoptosis after neonatal ischemic brain damage (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23376684
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24854329
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
top
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26260390
Effects of Cannabidiol and Hypothermia on Short-Term Brain Damage in New-Born Piglets after Acute Hypoxia-Ischemia (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4940392/
Short-term effects of cannabidiol after global hypoxia-ischemia in newborn piglets (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27441365
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686886


PHARC/POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA and CATARACT SYNDROME
Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2933347/?toolubmed
The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2‐arachidonoylglycerol signalling through cannabinoid receptors (full–2011) http/onlinelibrary.wiley.com/doi/10.1111/j.1748-1716.2011.02280.x/full
Targeted next-generation sequencing identifies a homozygous nonsense mutation in ABHD12, the gene underlying PHARC, in a family clinically diagnosed with Usher syndrome type 3 (full–2012) http/www.ojrd.com/content/7/1/59
ABHD12 controls brain lysophosphatidylserine pathways that are deregulated in a murine model of the neurodegenerative disease PHARC (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3557017/
Two Novel Mutations in ABHD12: Expansion of the Mutation Spectrum in PHARC and Assessment of Their Functional Effects (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24027063
Discovery of triterpenoids as reversible inhibitors of α/β-hydrolase domain containing 12 (ABHD12) (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4045134/
Exome sequencing extends the phenotypic spectrum for ABHD12 mutations: from syndromic to nonsyndromic retinal degeneration (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24697911


PLACEBO EFFECT
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21963514
Placebo-induced improvements: how therapeutic rituals affect the patient’s brain (full–2012) http://www.jams-kpi.com/article/S2005-2901%2812%2900031-3/fulltext
The Neurobiology of Placebo and Nocebo: How Expectations Influence Treatment Outcomes (full–2013) http/neuro.psychiatryonline.org/article.aspx?articleid=1770382&resultClick=1
FAAH selectively influences placebo effects (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24042479
Molecular mechanisms of placebo responses in humans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25510510
Nocebo and placebo modulation of hypobaric hypoxia headache involves the cyclo-oxygenase-prostaglandins pathway (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24462931
top
The sweetest pill to swallow: How patient neurobiology can be harnessed to maximise placebo effects (abst–2014) http://www.sciencedirect.com/science/article/pii/S0149763413002157
Cannabinoids and Epilepsy (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
Placebo and nocebo effects: a complex interplay between psychological factors and neurochemical networks (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25928679
The placebo effect: from concepts to genes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26272535
Placebos: Honest fakery (article–2016) http://www.nature.com/nature/journal/v535/n7611_supp/full/535S14a.html
Placebo effect: clinical, biological and therapeutical involvements in depression (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26879253
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27286745
Nature of the placebo and nocebo effect in relation to functional neurologic disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27719874


POISONING-HEAVY METAL
Protective effect of cannabidiol against cadmium hepatotoxicity in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23993482
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
Arsenic decreases antinociceptive activity of paracetamol: Possible involvement of serotonergic and endocannabinoid receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25128769
Effective Phytoextraction of Cadmium (Cd) with Increasing Concentration of Total Phenolics and Free Proline in Cannabis sativa (L) Plant Under Various Treatments of Fertilizers, Plant Growth Regulators and Sodium Salt (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25174425
Differential effects and potential adverse outcomes of ionic silver and silver nanoparticles in vivo and in vitro (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24684273
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26366840


POISONING-ORGANOPHOSPHATE
Behavioral sequelae following acute diisopropylfluorophosphate intoxication in rats: comparative effects of atropine and cannabinomimetics (full–2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2854260/?toolubmed
Cannabinoid Receptor Agonist WIN-55,212-2 Protects Differentiated PC12 Cells From Organophosphorus- Induced Apoptosis (abst–2010) http/ijt.sagepub.com/content/29/2/201.abstract
Activity-based protein profiling of organophosphorus and thiocarbamate pesticides reveals multiple serine hydrolase targets in mouse brain (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3071868/
Comparative effects of chlorpyrifos in wild type and cannabinoid Cb1 receptor knockout mice (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3205254/
Effect of Developmental Chlorpyrifos Exposure on Endocannabinoid Metabolizing Enzymes in the Brain of Juvenile Rats (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3143466/
top
Inhibition of recombinant human carboxylesterase 1 and 2 and monoacylglycerol lipase by chlorpyrifos oxon, paraoxon and methyl paraoxon (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3345137/
Acetaminophen, pesticide, and diethylhexyl phthalate metabolites, anandamide, and fatty acids in deciduous molars: potential biomarkers of perinatal exposure (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22805989
Induction of Endocannabinoid Levels in Juvenile Rat Brain Following Developmental Chlorpyrifos Exposure (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23761300
Comparative effects of parathion and chlorpyrifos on extracellular endocannabinoid levels in rat hippocampus: Influence on cholinergic toxicity (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23933531
Low Level Chlorpyrifos Exposure Increases Anandamide Accumulation in Juvenile Rat Brain in the Absence of Brain Cholinesterase Inhibition (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24373905
Neuroactive insecticides: targets, selectivity, resistance, and secondary effects (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23317040
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23296873
The cannabinoid receptor antagonist AM251 increases paraoxon and chlorpyrifos oxon toxicity in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25447325
Organophosphate agents induce plasma hypertriglyceridemia in mouse via single or dual inhibition of the endocannabinoid hydrolyzing enzyme(s) (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24361246
Fenitrothion action at the endocannabinoid system leading to spermatotoxicity in Wistar rats (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24998969
Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon induced seizures (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/prp2.100/full
COMPARATIVE EFFECTS OF PARATHION AND CHLORPYRIFOS ON ENDOCANNABINOID AND ENDOCANNABINOID-LIKE LIPID METABOLITES IN RAT STRIATUM (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26215119
Decreased anxiety in juvenile rats following exposure to low levels of chlorpyrifos during development (abst–2015) http://www.sciencedirect.com/science/article/pii/S0161813X15300322
top


POISONING-OTHER
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138


POISONING-PARAQUAT
Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain mitochondria upon paraquat exposure (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20514518
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full–2014) http/www.hindawi.com/journals/bmri/2014/971750/
Determination of Herbicides Paraquat, Glyphosate, and Aminomethylphosphonic Acid in Marijuana Samples by Capillary Electrophoresis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25413634


POISONING–ROTENONE
Phytocannabinoids tetrahydrocannabinol and cannabidiol act against rotenone induced damages in murine cell cultures (abst–2012) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0032-1320529
The effect of cannabis on oxidative stress and neurodegeneration induced by intrastriatal rotenone injection in rats (abst–2015) http://link.springer.com/article/10.1007/s00580-014-1907-9
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/


POLLS and SURVEYS
Survey on the use of psychotropic drugs by twelve military police units in the municipalities of Goiânia and Aparecida de Goiânia, state of Goiás, Brazil (full–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000400012&lng=en&nrm=iso&tlng=en
Survey of alcohol, tobacco, and cannabis use in the French army (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20390703
Posttraumatic stress disorder and Cannabis use in a nationally representative sample (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480682
Prevalence and co-use of marijuana among young adult cigarette smokers: An anonymous online national survey (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507655/
Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients (full–2012) https://philippelucasvictoria.files.wordpress.com/2012/12/rx-mj-as-a-substitute-for-aod-addiction-researchand-theory-2012-in-press.pdf
Prospectively Surveying Health-Related Quality of Life and Symptom Relief in a Lot Based Sample of Medical Cannabis-Using Patients in Urban Washington State Reveals Managed Chronic Illness and Debility (full–2012) http://journals.sagepub.com/doi/full/10.1177/1049909112454215
A questionnaire survey of patients and carers of patients prescribed Sativex as an unlicensed medicine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22784399
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4107777/
Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment resistant epilepsy (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4157067/
top
Clinical decisions. Medicinal use of marijuana – polling results (article–2013) http://www.nejm.org/doi/full/10.1056/NEJMclde1305159
Identity formation, marijuana and “the self”: a study of cannabis normalization among university students (article–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00160/full
Statistics on cannabis users skew perceptions of cannabis use (article–2013) http://journal.frontiersin.org/article/10.3389/fpsyt.2013.00138/full
The medicinal use of cannabis and cannabinoids-an international cross-sectional survey on administration forms (abst–2013) http://www.unboundmedicine.com/medline/citation/24175484/The_medicinal_use_of_cannabis_and_cannabinoids–an_international_cross-sectional_survey_on_administration_forms.
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
A survey of synthetic cannabinoid consumption by current cannabis users (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048873/
Health Poll – Legalizing Marijuana (full–2014) http://truvenhealth.com/Portals/0/NPR-Truven-HealthPoll/TRU_13728_0414_NPRPulseMarijuanaStudy.pdf
Drug use, consequences and perceived accessibility in three Nigerian universities (full–2014) http://file.scirp.org/Html/9-1420229_41669.htm
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
Substance Use among Medical Students: A Literature Review 1988- 2013 (full–2015) http://www.actaspsiquiatria.es/repositorio//17/95/ENG/17-95-ENG-109-21-286815.pdf
Medical marijuana laws and adolescent marijuana use in the USA from 1991 to 2014: results from annual, repeated cross-sectional surveys (full–2015) http://press.thelancet.com/AdolescentMarijuana.pdf
A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25553163
A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4277530/
Drugs and Crime Facts (full–2015) http://www.bjs.gov/content/dcf/ptrpa.cfm
Cannabis in medicine: a national educational needs assessment among Canadian physicians (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374299/
State Estimates of Adolescent Marijuana Use and Perceptions of Risk of Harm From Marijuana Use: 2013 and 2014 (full–2015) http://www.samhsa.gov/data/sites/default/files/report_2121/ShortReport-2121.html
Prevalence and determinants of cannabinoid prescription for the management of chronic noncancer pain: a postal survey of physicians in the Abitibi-Témiscamingue region of Quebec (full–2015) http://cmajopen.ca/content/3/2/E251.full?sid=139f05c1-b441-476b-99ff-addf8c918e1a
top
High School Students’ Use of Electronic Cigarettes to Vaporize Cannabis (full–2015) http://pediatrics.aappublications.org/content/136/4/611.long
Synthetic cannabinoid use in a nationally representative sample of US high school seniors (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4361370/
Perceived risk of regular cannabis use in the United States from 2002 to 2012: Differences by sex, age, and race/ethnicity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25735467
ADOLESCENTS’ USE OF MEDICAL MARIJUANA: A SECONDARY ANALYSIS OF MONITORING THE FUTURE DATA (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514911/
Medicinal Cannabis: A Survey Among Health Care Providers in Washington State (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26377551
Self-reported use of novel psychoactive substances in a US nationally representative survey: Prevalence, correlates, and a call for new survey methods to prevent underreporting (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901622-1/abstract
Characteristics of novel psychoactive substance exposures reported to New York City Poison Center, 2011-2014 (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767576/
Cannabis use, depression and anxiety: A 3-year prospective population-based study (link to PDF–2015) http://www.jad-journal.com/article/S0165-0327%2815%2931030-2/abstract
Change in perceived risk associated with marijuana use in the United States from 2002 to 2012 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25646638
Longitudinal Effects of School Drug Policies on Student Marijuana Use in Washington State and Victoria, Australia (abst–2015) http://ajph.aphapublications.org/doi/10.2105/AJPH.2014.302421
A safer alternative: Cannabis substitution as harm reduction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25919477
Novel psychoactive substance use by US adolescents: Characteristics associated with use of synthetic cannabinoids and synthetic cathinones (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26711540
Legal issues for German-speaking cannabis growers. Results from an online survey (abst–2015) http://www.ijdp.org/article/S0955-3959%2815%2900315-1/abstract
Sexual identity and prevalence of alcohol and other drug use among Australians in the general population (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26691433
In the weeds: a baseline view of cannabis use among legalizing states and their neighbours (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26687431
CANNABIS: ALTERNATIVE REALITIES (CRA) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26650405
Past 15-year trends in adolescent marijuana use: Differences by race/ethnicity and sex (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26361714
Patterns of cannabis use in patients with Inflammatory Bowel Disease: A population based analysis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26422462
Online survey characterizing vaporizer use among cannabis users (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901835-9/abstract
Marijuana experiences, voting behaviors, and early perspectives regarding marijuana legalization among college students from 2 states (abst – 2015) http://www.tandfonline.com/doi/full/10.1080/07448481.2015.1062769?src=recsys
Prioritizing Alcohol Prevention: Establishing Alcohol as the Gateway Drug and Linking Age of First Drink With Illicit Drug Use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/josh.12351/full
top
Adult attention deficit hyperactivity disorder symptom profiles and concurrent problems with alcohol and cannabis: sex differences in a representative, population survey (full–2016) http://bmcpsychiatry.biomedcentral.com/articles/10.1186/s12888-016-0746-4
Genome-wide association study of lifetime cannabis use based on a large meta-analytic sample of 32 330 subjects from the International Cannabis Consortium (full–2016) http://www.nature.com/tp/journal/v6/n3/full/tp201636a.html
The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists’ Perspectives (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155113
Attitudes of Israeli Rheumatologists to the Use of Medical Cannabis as Therapy for Rheumatic Disorders (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4839539/ Drug abuse in slum population (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776588/
Socio-Demographic Factors Associated with Psychoactive Substance Use among Commercial Motorcycle Operators in Kano, Nigeria (full – 2016) http://file.scirp.org/Html/9-1420373_62853.htm
National Estimates of Marijuana Use and Related Indicators – National Survey on Drug Use and Health, United States, 2002–2014 (full–2016) http://www.cdc.gov/mmwr/volumes/65/ss/ss6511a1.htm?s_cid=ss6511a1_e
Highlights of the 2011 Drug Abuse Warning Network (DAWN) Findings on Drug Related Emergency Department Visits (full–2016) http://www.ncbi.nlm.nih.gov/books/NBK384680/
Effectiveness of the synthetic cannabinoids seminar (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5121273/
Minnesota Pharmacists and Medical Cannabis: A Survey of Knowledge, Concerns, and Interest Prior to Program Launch (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083080/
Marijuana: Views on Its Medical Use Recorded at the Slovak Social Network (full–2016) http://journals.sagepub.com/doi/full/10.1177/0047237916646442
Opinions of Hospital Pharmacists in Canada Regarding Marijuana for Medical Purposes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4853179/
American Attitudes toward Substance Use in the United States (link to PDF–2016) http://www.apnorc.org/projects/Pages/american-attitudes-toward-substance-use-in-the-united-states.aspx
COMPREHENSIVE MEDICAL MARIJUANA PATIENT STUDY (link to PDF–2016) https://www.hellomd.com/medical-marijuana-patient-survey Working on a Standard Joint Unit: A pilot test. (link to download in English–2016) Descargar el archivo PDF The widening gender gap in marijuana use prevalence in the U.S. during a period of economic change, 2002-2014. (link via ELSEVIER to Full Text–2016) https://www.ncbi.nlm.nih.gov/pubmed/27875801 Drug abuse in nursing students (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26827249
Comparing adults who use cannabis medically with those who use recreationally: Results from a national sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262964 Traffic accidentability and risky driving behavior in young people in New Caledonia Results of study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27259836
Pediatric oncology providers and use of medical marijuana in children with cancer (abst–2016) http://meetinglibrary.asco.org/content/170798-176
New Zealand Health Survey 2012/13: characteristics of medicinal cannabis users (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27349158
The association between cannabis use and anxiety disorders: Results from a population based representative sample (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26775742
A comparison between wastewater-based drug data and an illicit drug use survey in a selected community (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450319 Integrating environmental and self-report data to refine cannabis prevalence estimates in a major urban area of Switzerland (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27455466
Early Survey Results from the Minnesota Medical Cannabis Program (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27464390
Clinical trials of medicinal cannabis for appetite-related symptoms from advanced cancer: A survey of preferences, attitudes and beliefs among patients willing to consider participation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27530738
Risky substance use and peer pressure in Swiss young men: Test of moderation effects (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27632359
The replicability of cannabis use prevalence estimates in the United States (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27658846
Bongs and baby boomers: Trends in cannabis use among older Australians (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27730759
Determining Cannabis Use Status From a Photograph: An Assessment of the “Jay-dar” in Neuropsychologists (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27779445 Pseudo-Underage Assessment of Compliance With Identification Regulations at Retail Marijuana Outlets in Colorado (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797687
Survey of herbal cannabis (marijuana) use in rheumatology clinic attenders with a rheumatologist confirmed diagnosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842047
Got Munchies? Estimating the Relationship between Marijuana Use and Body Mass Index (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27572145
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478
Demographic trends among older cannabis users in the United States, 2006–13 (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27767235
The association between cannabis use and motivation and intentions to quit tobacco within a sample of Australian socioeconomically disadvantaged smokers (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27923866
Is the Legalization of Marijuana Associated With Its Use by Adolescents? (abst–2016) http://www.tandfonline.com/doi/full/10.1080/10826084.2016.1223139?src=recsys
Attitudes to cannabis and patterns of use among Canadians with multiple sclerosis (abst – 2016) https://www.ncbi.nlm.nih.gov/pubmed/27919478 Attitudes towards drug policies in Latin America: Results from a Latin-American Survey (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27988428
Substance Use, Health, and Functioning Characteristics of Medical Marijuana Program Participants Compared to the General Adult Population in Ontario (Canada) (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28001910
Irish general practitioner attitudes toward decriminalisation and medical use of cannabis: results from a national survey (full–2017) https://harmreductionjournal.biomedcentral.com/articles/10.1186/s12954-016-0129-7 Cannabis use in persons with traumatic spinal cord injury in Denmark. (link to PDF- 2017) https://www.medicaljournals.se/jrm/content/abstract/10.2340/16501977-2105
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured interview study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28040884
Support for Marijuana Legalization and Predictors of Intentions to Use Marijuana More Often in Response to Legalization Among U.S. Young Adults (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/27976988
Do recreational cannabis users, unlicensed and licensed medical cannabis users form distinct groups? (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107687


POLLUTION/ENVIRONMENT
Drugs of abuse in airborne particulates in urban environments (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20447692
Potential exposures associated with indoor marijuana growing operations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24116667
Cannabis, Pesticides and Conflicting Laws: the Dilemma for Legalized States and Implications for Public Health (abst–2014) http://www.sciencedirect.com/science/article/pii/S027323001400097X
Effective Phytoextraction of Cadmium (Cd) with Increasing Concentration of Total Phenolics and Free Proline in Cannabis sativa (L) Plant Under Various Treatments of Fertilizers, Plant Growth Regulators and Sodium Salt (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25174425
Impacts of surface water diversions for marijuana cultivation on aquatic habitat in four northwestern California watersheds (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0120016
Patterns of Natural and Human-Caused Mortality Factors of a Rare Forest Carnivore, the Fisher (Pekania pennanti) in California (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633177/
Phytoaccumulation of Heavy Metals in Natural Vegetation at the Municipal Wastewater Site in Abbottabad, Pakistan (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26366840
High Time for Conservation: Adding the Environment to the Debate on Marijuana Liberalization (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776720/
The increase of cannabis use may indirectly affect the health status of a freshwater species (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27496769
Phytoextraction of heavy metals by potential native plants and their microscopic observation of root growing on stabilised distillery sludge as a prospective tool for in situ phytoremediation of industrial waste (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27826829
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138


POST-OPERATIVE PAIN
Evidence for a Role of Endocannabinoids, Astrocytes and p38 Phosphorylation in the Resolution of Postoperative Pain (full–2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2878341/?toolmcentrez
Historical essay: An Arabic surgeon, Ibn al Quff’s (1232-1286) account on surgical pain relief (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4173333/
Peripheral and Spinal Activation of Cannabinoid Receptors by Joint Mobilization Alleviates Postoperative Pain in Mice (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24120553
Postoperative Analgesia in the Jamaican Cannabis User (abst–2013) http/www.tandfonline.com/doi/full/10.1080/02791072.2013.803644#.U9QCtWN8E24
Intrathecal Injection of JWH015 Attenuates Remifentanil-Induced Postoperative Hyperalgesia by Inhibiting Activation of Spinal Glia in a Rat Model (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24651239
Interaction of a Cannabinoid-2 Agonist With Tramadol on Nociceptive Thresholds and Immune Responses in a Rat Model of Incisional Pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25370921
Endocannabinoids and acute pain after total knee arthroplasty (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25599456
The prescription of medical cannabis by a transitional pain service to wean a patient with complex pain from opioid use following liver transplantation : a case report (full–2015) http://link.springer.com/article/10.1007%2Fs12630-015-0525-6
Effect of endocannabinoid degradation on pain: role of FAAH polymorphisms in experimental and postoperative pain in women treated for breast cancer (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26808012
top


POST POLIO SYNDROME
Post-Polio Syndrome and Marijuana Information: Treat Post-Polio Syndrome With Cannabis (news–undated) https://unitedpatientsgroup.com/post-polio-syndrome-and-marijuana-treat-PPS-withcannabis
Medical Marijuana Coverage Still Lost in the Legal Weeds (article–2013) http://www.managedcaremag.com/linkout/2013/1/23


POST-TRAUMATIC STRESS DISORDER/FEAR EXTINCTION
The use of Cannnabidiol (CBD) and Meditation to reduce Binge Drinking, Anxiety and to improve Emotional Regulation in Long Term Behavior Therapy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/437/?pagenum=2
PTSD contributes to teen and young adult cannabis use disorders (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784238/?tool=pubmed
Endocannabinoids and psychiatric disorders: the road ahead (article–2010) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462010000500003&lng=en&nrm=iso&tlng=en
Cannabinoids modulate hippocampal memory and plasticity (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19830813
The relationship between substance use and posttraumatic stress disorder in a methadone maintenance treatment program (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=309
The role of cannabinoids in modulating emotional and non-emotional memory processes in the hippocampus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124830/?tool=pubmed
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Anti-Aversive Effects of Cannabidiol on Innate Fear-Induced Behaviors Evoked by an Ethological Model of Panic Attacks Based on a Prey vs the Wild Snake Epicrates cenchria crassus Confrontation Paradigm (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242302/
Posttraumatic Stress and Marijuana Use Coping Motives: The Mediating Role of Distress Tolerance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101637/
Posttraumatic stress disorder and Cannabis use in a nationally representative sample (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21480682
Cannabinoid receptor expression and phosphorylation are differentially regulated between male and female cerebellum and brain stem after repeated stress: Implication for PTSD and drug abuse (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21600961
Effect of cannabidiol on sleep disruption induced by the repeated combination tests consisting of open field and elevated plus-maze in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21867717
Medical cannabis use in post-traumatic stress disorder: a naturalistic observational study (abst–2011) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=481
Cannabis use among military veterans after residential treatment for posttraumatic stress disorder (abst–2011) http://marijuana.researchtoday.net/archive/8/9/5260.htm
Cannabidiol, a Cannabis sativa constituent, as an anxiolytic drug (full–2012) http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1516-44462012000500008&lng=en&nrm=iso&tlng=en
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242309/
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Convergent translational evidence of a role for anandamide in amygdala-mediated fear extinction, threat processing and stress-reactivity (full–2012)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3549323/
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full–2012) http://www.jneurosci.org/content/32/21/7109.long
On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398715/
top
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565211/
CADTH Rapid Response Report: Cannabinoids for the treatment of post-traumatic stress disorder (full–2012) http://www.cadth.ca/media/pdf/htis/july-2012/RC0368%20Cannabinoids%20Final.pdf
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Fear relief-toward a new conceptual frame work and what endocannabinoids gotta do with it (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22173015
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22579951
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22534181
Mitigation of post-traumatic stress symptoms by Cannabis resin: A review of the clinical and neurobiological evidence (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22736575
Prevalence of Cannabis Use Disorder Diagnoses Among Veterans in 2002, 2008, and 2009 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22564034
The underdiagnosis of cannabis use disorders and other Axis-I disorders among military veterans within VHA (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22808884
Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21906661
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: Possible involvement of 5HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22979992
CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23018128
Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21148020 Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22979992 Cognitive ability in early adulthood as a predictor of habitual drug use during later military service and civilian life: the Vietnam Experience Study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22520690
Positron emission tomography offers new perspectives for evidence-based treatment development in PTSD (abst-forum repost–2012) http://forum.grasscity.com/medical-marijuana-usage-applications/1374895-ptsd-study.html
Plasma concentrations of endocannabinoids and related primary Fatty Acid amides in patients with post-traumatic stress disorder (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062741
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752332/
top
Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883309/
The endocannabinoid system as a possible target to treat both the cognitive and emotional features of post-traumatic stress disorder (PTSD) (full–2013) http://www.frontiersin.org/Behavioral_Neuroscience/10.3389/fnbeh.2013.00100/full
Recent Progress in Understanding the Pathophysiology of Post-Traumatic Stress Disorder: Implications for Targeted Pharmacological Treatment (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629370/
Translational evidence for the involvement of the endocannabinoid system in stress related psychiatric illnesses (full–2013) http://www.biolmoodanxietydisord.com/content/3/1/19
Cannabinoid facilitation of fear extinction memory recall in humans (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3445738/
Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor (full–2013) http://ijnp.oxfordjournals.org/content/16/8/1781.long
The endocannabinoid system and emotional processing: A pharmacological fMRI study with ∆9-tetrahydrocannabinol (full–2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900195-8/fulltext
Reductions in circulating endocannabinoid levels in individuals with post-traumatic stress disorder following exposure to the world trade center attacks (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870889/
Amygdala FAAH and anandamide: mediating protection and recovery from stress (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169112/
Using cannabis to help you sleep: Heightened frequency of medical cannabis use among those with PTSD (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929256/
Toward Rational Pharmacotherapy for Posttraumatic Stress Disorder: Reprise (editorial–2013) http://ajp.psychiatryonline.org/article.aspx?articleid=1734484&resultClick=3
Correspondence (letter to the editor): Cannabis Therapy (letter–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601285/
The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD. (1st page–2013) http://onlinelibrary.wiley.com/doi/10.1002/da.22031/abstract
A current overview of cannabinoids and glucocorticoids in facilitating extinction of aversive memories: Potential extinction enhancers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22687521
Predator threat stress promotes long lasting anxiety-like behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23178193
Cannabidiol enhances consolidation of explicit fear extinction in humans (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23307069
Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23433741
top
Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23643693
Cannabinoids and glucocorticoids modulate emotional memory after stress (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23954749
Effects of endocannabinoid and endovanilloid systems on aversive memory extinction (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23948212
Fatty acid ethanolamide levels are altered in borderline personality and complex posttraumatic stress disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24253425
Posttraumatic stress disorder and cannabis use characteristics among military veterans with cannabis dependence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23617872
PTSD Symptom Reports of Patients Evaluated for the New Mexico Medical Cannabis Program (full–2014) http://www.tandfonline.com/doi/full/10.1080/02791072.2013.873843#tabModule
Impaired Fear Memory Specificity Associated with Deficient EndocannabinoidDependent Long-Term Plasticity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4023141/
Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder (full–2014) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900396-5/fulltext
Cannabinoid Modulation of Amygdala Subregion Functional Connectivity to Social Signals of Threat (full-2014) http://ijnp.oxfordjournals.org/content/18/3/pyu104.long
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (full–2014) http://www.jneurosci.org/content/34/39/13096.long
Use of a Synthetic Cannabinoid in a Correctional Population for Post-traumatic Stress Disorder-Related Insomnia and Nightmares, Chronic Pain, Harm Reduction, and Other Indications: A Retrospective Evaluation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165471/
Stress regulates endocannabinoid-CB1 receptor signaling (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247817/
Drug discovery strategies that focus on the endocannabinoid signaling system in psychiatric disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4696509/
Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207337/
Positive posttraumatic stress disorder screens among first-time medical cannabis patients: Prevalence and association with other substance use (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4299455/
Interaction between the Cholecystokinin and Endogenous Cannabinoid Systems in Cued Fear Expression and Extinction Retention (full–2014) http://www.nature.com/npp/journal/v40/n3/full/npp2014225a.html
Toward a translational approach to targeting the endocannabinoid system in post-traumatic stress disorder: A critical review of preclinical research (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4465924/
Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3960373/ Endocannabinoid Signaling within the Basolateral Amygdala Integrates Multiple Stress Hormone Effects on Memory Consolidation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397407/
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors (full–2014) http://www.nature.com/npp/journal/v39/n8/pdf/npp201432a.pdf
top
Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing (link to PDF–2014) http://www.nature.com/npp/journal/v39/n12/full/npp2014132a.html
Modulation of the extinction of fear learning (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24742526
When time stands still: an integrative review on the role of chronodisruption in post-traumatic stress disorder (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25023884
Marijuana, expectancies, and post-traumatic stress symptoms: a preliminary investigation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25052875
The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25069241
Preliminary, open-label, pilot study of add-on oral δ(9)-tetrahydrocannabinol in chronic post-traumatic stress disorder (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24935052
The learning of fear extinction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25452113
PTSD Growth and Substance Abuse Among a College Student Community: Coping Strategies after 2009 L’aquila Earthquake (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4397827/
Increased contextual fear conditioning in iNOS knockout mice: additional evidence for the involvement of nitric oxide in stress-related disorders and contribution of the endocannabinoid system (full–2015) http://ijnp.oxfordjournals.org/content/18/8/pyv005.long
The efficacy of nabilone, a synthetic cannabinoid, in the treatment of PTSD-associated nightmares: A preliminary randomized, double-blind, placebo-controlled cross-over design study (full–2015) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900413-2/fulltext
Metabolite profiling in posttraumatic stress disorder (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4367823/
Training-Associated Emotional Arousal Shapes Endocannabinoid Modulation of Spatial Memory Retrieval in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26468197
The endocannabinoid system in guarding against fear, anxiety and stress (abst–2015) http://www.nature.com/nrn/journal/v16/n12/full/nrn4036.html
Cannabidiol as a Potential Treatment for Anxiety Disorders (abst–2015) http://link.springer.com/article/10.1007/s13311-015-0387-1
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling (abst–2015) http://www.cell.com/cell/abstract/S0092-8674%2815%2900826-0?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0092867415008260%3Fshowall%3Dtrue
Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25981172
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26628106
Investigational drugs under development for the treatment of PTSD (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25773140
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25799920
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25814137
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
The influence of cannabinoids on learning and memory processes of the dorsal striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092091
Use and effects of cannabinoids in military veterans with posttraumatic stress disorder (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26195653
Providing a food reward reduces inhibitory avoidance learning in zebrafish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26342856
Endocannabinoids and Mental Disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408164
Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815303259
Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815302161
Marijuana dependence moderates the effect of posttraumatic stress disorder on trauma cue reactivity in substance dependent patients (abst–2015) http://www.sciencedirect.com/science/article/pii/S0376871615018293
Being the Victim of Violence during a Date predicts Next-Day Cannabis Use among Female College Students (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26449928
top
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25799920
Cannabinoid Receptors May Control Aversive Memories (news & abstract-2015) http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory (full–2016) http://www.hindawi.com/journals/np/2016/9817089/
top
2-arachidonoylglycerol signaling impairs short-term fear extinction (full–2016) http://www.nature.com/tp/journal/v6/n3/full/tp201626a.html
Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726806/
Cannabis use among Navy personnel in Sri Lanka: a cross sectional study (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4794863/
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (full–2016) https://elifesciences.org/content/5/e14137
Genetic variation in the endocannabinoid system and response to Cognitive Behavior Therapy for child anxiety disorders (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/ajmg.b.32467/full
PTSD: from neurobiology to pharmacological treatments (full–2016) http://www.ejpt.net/index.php/ejpt/article/view/31858
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00454/full
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993868/
Modulation of cannabinoid signaling by hippocampal 5-HT4 serotonergic system in fear conditioning (full–2016) http://journals.sagepub.com/doi/full/10.1177/0269881116652584
Bidirectional Effects of Cannabidiol on Contextual Fear Memory Extinction (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00493/full
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Sex differences in hippocampal response to endocannabinoids after exposure to severe stress (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26928784
Endocannabinoid concentrations in hair are associated with PTSD symptom severity (abst–2016) http://www.psyneuen-journal.com/article/S0306-4530%2816%2930040-3/abstract
The association of specific traumatic experiences with cannabis initiation and transition to problem use: Differences between African-American and European-American women (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27012434
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Associations of Posttraumatic Stress Disorder Symptoms With Marijuana and Synthetic Cannabis Use Among Young Adult U.S. Veterans: A Pilot Investigation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27172584
Cannabidiol Modulates Fear Memory Formation through Interactions with Serotonergic Transmission in the Mesolimbic System (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27296152
The endocannabinoid system and Post Traumatic Stress Disorder (PTSD): From preclinical findings to innovative therapeutic approaches in clinical settings (abst–2016) http://www.sciencedirect.com/science/article/pii/S104366181630706X
Factors associated with having a medical marijuana card among Veterans with recent substance use in VA outpatient treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27475408
Understanding resilience: New approaches for preventing and treating PTSD (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27417856
Cannabinoids and post-traumatic stress disorder: clinical and preclinical evidence for treatment and prevention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27551883
Dorsal hippocampus cannabinoid type 1 receptors modulate the expression of contextual fear conditioning in rats: Involvement of local glutamatergic/nitrergic and GABAergic neurotransmissions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27591981
Cannabinoid CB1 receptors in distinct circuits of the extended amygdala determine fear responsiveness to unpredictable threat (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27698427
FAAH Gene Variation Moderates Stress Response and Symptom Severity in Patients with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27716956
Targeting the Endocannabinoid System in Psychiatric Illness (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27811555
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
Considering Future Pharmacotherapy for PTSD (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016309004
Cannabinoid modulation of zebrafish fear learning and its functional analysis investigated by c-Fos expression (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302854
Marijuana Could Help Treat Drug Addiction and Mental Health Problems (news & abst–2016) http://neurosciencenews.com/addiction-mental-health-marijuana-5536/
Medicinal versus recreational cannabis use: Patterns of cannabis use, alcohol use, and cued-arousal among veterans who screen positive for PTSD (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28088054
The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal-amygdala-insular circuit (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131675


POTENCY
Potency trends of Δ9-THC and other cannabinoids in confiscated cannabis preparations from 1993 to 2008 (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20487147/abstract/Potency_trends_of_%CE%949_THC_and_other_cannabinoids_in_confiscated_cannabis_preparations_from_1993_to_2008_
How Accurate is Potency Testing? (full–2011) http://www.canorml.org/RingTestOShaughnessys_Aut11.pdf
The Effect of Electrical Lighting Power and Irradiance on Indoor-Grown Cannabis Potency and Yield (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211717
Is today’s marijuana more potent simply because it’s fresher? (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/dta.1430/full
A survey of the potency of Japanese illicit cannabis in fiscal year 2010 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22554871
Evolution of the Content of THC and Other Major Cannabinoids in Drug-Type Cannabis Cuttings and Seedlings During Growth of Plants (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22390363
First systematic evaluation of the potency of Cannabis sativa plants grown in Albania (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22608266
Cannabis Strain Explorer (web page–2012) http://www.leafly.com/explore
Michael Pollan: What Do Marijuana and Catnip Have in Common? (news–2012) http://www.alternet.org/drugs/148510/michael_pollan:_what_do_marijuana_and_catnip_have_in_common/
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0070052
Cannabis, a complex plant: different compounds and different effects on individuals (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3736954/
Cannabis affects people differently: inter-subject variation in the psychotogenic effects of Δ9-tetrahydrocannabinol: a functional magnetic resonance imaging study with healthy volunteers (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23020923
THE EFFECT OF ABA ON PIGMENTS AND TETRAHYDROCANNABINOL IN CANNABIS SATIVA AT FLOWERING STAGE (abst–2013) http://en.journals.sid.ir/ViewPaper.aspx?ID=351874
Variability of cannabis potency in the Venice area (Italy): A survey over the period 2010- 2012 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23868754
Variability of cannabis potency in the Venice area (Italy): A survey over the period 2010-2012 (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/dta.1515/full
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24628797
Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/add.12508/full
Therapeutic Satisfaction and Subjective Effects of Different Strains of Pharmaceutical Grade Cannabis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747979
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
top
Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24894801
Acute subjective effects after smoking joints containing up to 69 mg Δ9-tetrahydro-cannabinol in recreational users: a randomized, crossover clinical trial (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24879495
Selective monoacylglycerol lipase inhibitors: Antinociceptive vs cannabimimetic effects in mice (full–2015) http://jpet.aspetjournals.org/content/early/2015/03/11/jpet.114.222315.long
No smoke, no fire: What the initial literature suggests regarding vapourized cannabis and respiratory risk (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4456813/
Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26061356
Δ9-Tetrahydrocannabinol-like effects of novel synthetic cannabinoids found on the gray market (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4497846/
Marijuana gears up for production high in US labs (article–2015) http://www.nature.com/news/marijuana-gears-up-for-production-high-in-us-labs-1.17129
Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products (letter–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338239
Potency 101 (printable card set–2015) (good info!) http://greenstyleconsulting.com/potency-101/
Metabolism of classical cannabinoids and the synthetic cannabinoid JWH-018 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25788107
Sequence heterogeneity of cannabidiolic- and tetrahydrocannabinolic acid-synthase in Cannabis sativa L. and its relationship with chemical phenotype (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25865737
Effect of induced polyploidy on some biochemical parameters in Cannabis sativa L (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25492688
Evaluation of elemental profiling methods, including laser-induced breakdown spectroscopy (LIBS), for the differentiation of Cannabis plant material grown in different nutrient solutions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25898182
(1)H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26048837
Potency trends of Δ9 -THC, cannabidiol and cannabinol in cannabis in the Netherlands: 2005-2015 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26234170
Determination of the relative percentage distribution of THCA and Δ9-THC in herbal cannabis seized in Austria – Impact of different storage temperatures on stability (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26247127
top
Tetrahydrocannabinol pharmacokinetics; new synthetic cannabinoids; road safety and cannabis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26427296
Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/add.13390/full
Evaluating the Effects of Gamma-Irradiation for Decontamination of Medicinal Cannabis (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00108/full
Drug vaping applied to cannabis: Is “Cannavaping” a therapeutic alternative to marijuana? (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881394/
Evaluation of Two Commercially Available Cannabidiol Formulations for Use in Electronic Cigarettes (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00279/full
Dietary fats and pharmaceutical lipid excipients increase systemic exposure to orally administered cannabis and cannabis-based medicines (full–2016) http://www.ajtr.org/files/ajtr0030292.pdf
Traditional marijuana, high-potency cannabis and synthetic cannabinoids: increasing risk for psychosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032490/
Use of marijuana for medical purposes (click “Full Text Links” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27660881
Analysis of a commerical marijuana e-cigarette formulation (abst–2016) (This article has a delayed release and will be available in PMC on June 1, 2017) https://www.ncbi.nlm.nih.gov/pubmed/27059691
Changes in cannabis potency over the last two decades (1995-2014) – Analysis of current data in the United States (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006322316000457
Cannabinoids for treatment of glaucoma (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26840343
Cannabis-induced psychosis associated with high potency “wax dabs” (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876313
Analysis of a Commercial Marijuana e-Cigarette Formulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27059691
“Those edibles hit hard”: Exploration of Twitter data on cannabis edibles in the U.S. (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716%2816%2930056-4/abstract
Pharmacological characterization of emerging synthetic cannabinoids in HEK293T cells and hippocampal neurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27260125
Enhanced discriminative stimulus effects of Δ9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30133-8/abstract
Limitations to the Dutch cannabis toleration policy: Assumptions underlying the reclassification of cannabis above 15% THC (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27471078
Stability of Tetrahydrocannabinol and Cannabidiol in Prepared Quality Control Medible Brownies (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27798074
A study of cannabis potency in France over a 25 years period (1992-2016) (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28122324
Cannabinoid concentrations in Canada’s regulated medical cannabis industry (full–2017) http://onlinelibrary.wiley.com/doi/10.1111/add.13738/full
Comparison of the discriminative stimulus and response rate effects of Δ9- tetrahydrocannabinol and synthetic cannabinoids in female and male rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28130989


PRADER WILLI SYNDROME
Psychiatric adverse effects of rimonobant in adults with Prader Willi syndrome (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3038245/
Targeting the endocannabinoid/CB1 receptor system for treating obesity in Prader-Willi syndrome (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123200/


PREGNANCY/PRENATAL EXPOSURE
The Maternal Lifestyle Study: Sleep Problems in Children with Prenatal Substance Exposure (full–2010) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2917192/?toolubmed
N-Acylethanolamine Levels and Expression of Their Metabolizing Enzymes during Pregnancy (full–2010) http/endo.endojournals.org/content/151/8/3965.full
Effects of abnormal cannabidiol on oxytocin-induced myometrial contractility (full–2010) http://www.ncbi.nlm.nih.gov/pubmed/20068032
Cannabinoids and Reproduction: A Lasting and Intriguing History (link to PDF–2010) http/www.mdpi.com/1424-8247/3/10/3275
From Fertilisation to Implantation in Mammalian Pregnancy-Modulation of Early Human Reproduction by the Endocannabinoid System (link to PDF–2010) http/www.mdpi.com/1424-8247/3/9/2910
A prospective study on intrauterine cannabis exposure and fetal blood flow (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20451334
Tocolytic Effect of Δ9-Tetrahydrocannabinol in Mice Model of Lipopolysaccharide-Induced Preterm Delivery: Role of Nitric Oxide (abst–2010) http/rsx.sagepub.com/content/17/4/391.abstract
Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20369362
A common variation in the cannabinoid 1 receptor (CNR1) gene is associated with preeclampsia in the Central European population (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/21129839
Characteristics of pregnant illicit drug users and associations between cannabis use and perinatal outcome in a population-based study (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20171023
Endocannabinoids and pregnancy (abst–2010) http/www.ncbi.nlm.nih.gov/pubmed/20302856
Scientific Opinion on the safety of hemp (Cannabis genus) for use as animal feed (full–2011) (deceptive title) http/www.hanf-info.ch/info/en/IMG/pdf/EIHA-11-05-31_EIHA-Statement_on_THC_in_feed.pdf
top
Sex difference in cell proliferation in developing rat amygdala mediated by endo-cannabinoids has implications for social behavior (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?toolubmed
Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3188826/?toolubmed
The role of sex steroid hormones, cytokines and the endocannabinoid system in female fertility (full–2011) http://humupd.oxfordjournals.org/content/17/3/347.long
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?toolubmed
Modulation of the novel cannabinoid receptor – GPR55 – during rat fetoplacental development (full–2011) http://www.placentajournal.org/article/S0143-4004%2811%2900110-X/fulltext
Medical Marijuana: Can Pot Help Pregnant Women With Vomiting and Nausea? (article–2011) http/patients4medicalmarijuana.wordpress.com/2011/01/13/pregnancy-and-medical-marijuana-can-pothelp-pregnant-women-with-vomiting-and-nausea/
Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and vomiting of pregnancy (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21170540
Endocannabinoid signaling in female reproduction (full–2012) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3382454/
Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos (full–2012) http/molehr.oxfordjournals.org/content/19/2/93.full
Ectopic pregnancy is associated with high anandamide levels and aberrant expression of FAAH and CB1 in fallopian tubes (full–2012) http/press.endocrine.org/doi/full/10.1210/jc.2012-1780
Pharmacological characterization of the peripheral FAAH inhibitor URB937 in female rodents: interaction with the Abcg2 transporter in the blood-placenta barrier (full–2012) http/onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02098.x/full
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
Acetaminophen, pesticide, and diethylhexyl phthalate metabolites, anandamide, and fatty acids in deciduous molars: potential biomarkers of perinatal exposure (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22805989
Cannabinoid modulation of mother-infant interaction: is it just about milk? (abst–2012) http/www.degruyter.com/abstract/j/revneuro.2012.23.issue-5-6/revneuro-2012-0074/revneuro-2012-0074.xml?rskey=wRYgJd&result=1&q=cannabinoid
Elevated Anandamide and Related N-Acylethanolamine Levels Occur in the Peripheral Blood of Women With Ectopic Pregnancy and Are Mirrored by Changes in Peripheral Fatty Acid Amide Hydrolase Activity (full–2013) http/press.endocrine.org/doi/full/10.1210/jc.2012-3390
top
Detection of In Utero Marijuana Exposure by GC–MS, Ultra-Sensitive ELISA and LC–TOF–MS Using Umbilical Cord Tissue (full–2013) http/jat.oxfordjournals.org/content/early/2013/07/09/jat.bkt052.full
The role of endocannabinoids in pregnancy (full–2013) http/www.reproduction-online.org/content/early/2013/06/06/REP-12-0508.long
Embryonic diapause in humans: time to consider? (full–2013) http/www.rbej.com/content/11/1/92
The Effect of Mifepristone (RU486) on the Endocannabinoid System in Human Plasma and First Trimester Trophoblast of Women undergoing Termination of Pregnancy (abst–2013) http/press.endocrine.org/doi/abs/10.1210/jc.2013-2922?url_ver=Z39.88-2003&rfr_idri:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
Synthetic cannabinoids and potential reproductive consequences (abst-2013) http/www.ncbi.nlm.nih.gov/pubmed/23827241
Differential expression of endocannabinoid system in normal and preeclamptic placentas: effects on nitric oxide synthesis (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23122699
Of mice and (wo)men: factors influencing successful implantation including endocannabinoids (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24306146
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24008071
Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity (full–2013) http://www.placentajournal.org/article/S0143-4004%2813%2900692-9/fulltext
Long-term consequences of perinatal fatty acid amino hydrolase inhibition (abst–2013) http/onlinelibrary.wiley.com/doi/10.1111/bph.12500/abstract
Differential expression of endocannabinoid system in normal and preeclamptic placentas: Effects on nitric oxide synthesis (full–2013) http://www.placentajournal.org/article/S0143-4004%2812%2900393-1/fulltext
Detection of the endocannabinoid metabolome in human plasma and breast milk (abst–2013) http/www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/45.8?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Endocannabinoid receptor (CB1R) deficiency affects maternal care and alters the dam’s hippocampal oxytocin receptor and BDNF expression (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23895426
Diagnostic Value of Concentration Profiles of Glucocorticosteroids and Endocannabinoids in Hair (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23942543
Plasma Anandamide and Related N-acylethanolamide Levels are not Elevated in Pregnancies Complicated by Hyperemesis Gravidarum (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/24117326
Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/25444073
The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: Involvement of both mitochondrial and death receptor pathways (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25465706
The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: Involvement of both mitochondrial and death receptor pathways (full–2014) http://www.placentajournal.org/article/S0143-4004%2814%2900823-6/fulltext
Endocannabinoids as biomarkers of human reproduction (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24516083
Endocannabinoid Regulation in Human Endometrium Across the Menstrual Cycle (abst–2014) http/rsx.sagepub.com/content/early/2014/05/09/1933719114533730.abstract
Fatty Acid Binding Protein-4 is expressed in the mouse placental labyrinth, yet is dispensable for placental triglyceride accumulation and fetal growth (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/25096952
top
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24935942
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis (full–2014) http://hyper.ahajournals.org/content/64/3/619.long
Activity of anandamide (AEA) metabolic enzymes in rat placental bed (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25088244
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25409697
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies (abst–2014) http://www.nature.com/nrn/journal/v15/n12/full/nrn3846.html
Contribution of in utero drug exposure when interpreting hair results in young children (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25450508
Local uterine Ang-(1-7) infusion augments the expression of cannabinoid receptors and differentially alters endocannabinoid metabolizing enzymes in the decidualized uterus of pseudopregnant rats (full–2015) http://www.rbej.com/content/13/1/5
Increased Plasma Levels of FABP4 and PTEN Is Associated with More Severe Insulin Resistance in Women with Gestational Diabetes Mellitus (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4329941/
Decreased circulating anandamide levels in preeclampsia (full–2015) http://www.nature.com/hr/journal/v38/n6/full/hr201520a.html
Lipid mediator profile in vernix caseosa reflects skin barrier development (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629127/
Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26229240
Gestation Related Gene Expression of the Endocannabinoid Pathway in Rat Placenta (full–2015) http://www.hindawi.com/journals/mi/2015/850471/
A role for GPR55 in human placental venous endothelial cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25869640
Use of paracetamol during pregnancy and child neurological development (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25851072
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26144572
Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26347521
Progesterone and anandamide in pregnancy loss (abst–2015) http://www.placentajournal.org/article/S0143-4004%2815%2900515-9/fulltext
Cannabis conundrum: Evidence of harm?: Opposition to marijuana use is often rooted in arguments about the drug’s harm to children and adults, but the scientific evidence is seldom clear-cut (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21516/full
Participation of the endocannabinoid system (ECS) in the weight-gain and sensitization to LPS exposure in a maternal obesity model (article–2015) http://www.placentajournal.org/article/S0143-4004%2815%2900526-3/fulltext
CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/nyas.12642/full
top
[268-POS]: Placental expression of the endocannabinoid system in preeclampsia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25787618
[16-OR]: Vasoactive lipid mediators control uterine vascular reactivity at early pregnancy in the transgenic hAGNxhREN rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25787366
Endocannabinoid Levels in Newborns in Relation to the Mode of Delivery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25915139
Lipopolysaccharide-induced murine embryonic resorption involves changes in endo-cannabinoid profiling and alters progesterone secretion and inflammatory response by a CB1-mediated fashion (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958042
Anandamide restricts uterine stromal differentiation and is critical for complete decidualization (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25960165
Maternal marijuana use and neonatal morbidity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26026918
The endocannabinoid anandamide affects the synthesis of human syncytiotrophoblast related proteins (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26202891
Association between marijuana use and adverse obstetrical and neonatal outcomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26401751
Marijuana use and pregnancy: prevalence, associated characteristics, and birth outcomes  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25895138
Maternal age and trajectories of cannabis use (abst–2015) http://www.drugandalcoholdependence.com/article/S0376-8716%2815%2901662-2/abstract
Exposure to a Highly Caloric Palatable Diet During Pregestational and Gestational Periods Affects Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Adiposity and Anxiety-Like Behaviors in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00339/full
top
Sustained Endocannabinoid Signaling Compromises Decidual Function and Promotes Inflammation-induced Preterm Birth (full–2016) http://www.jbc.org/content/early/2016/02/21/jbc.M115.707836.long
Differential Regulation of Eicosanoid and Endocannabinoid Production by Inflammatory Mediators in Human Choriodecidua (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148306
Maternal marijuana use has independent effects on risk for spontaneous preterm birth but not other common late pregnancy complications (full–2016) http://www.sciencedirect.com/science/article/pii/S0890623816300715
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Anandamide interferes with human endometrial stromal-derived cell differentiation: An effect dependent on inhibition of cyclooxygenase-2 expression and prostaglandin E2 release (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26945481
The endocannabinoid system: an emergent player in human placentation (abst–2016) http://www.sciencedirect.com/science/article/pii/S0890623816300260
Alcohol, Methamphetamine, and Marijuana Exposure Have Distinct Effects on the Human Placenta (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27038593
Conceptus development and transcriptome at preimplantation stages in lactating dairy cows of distinct genetic groups and estrous cyclic statuses (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27016828
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production (abst–2016) http://www.jrijournal.org/article/S0165-0378%2816%2930026-2/abstract
Dietary conjugated linoleic acid supplementation alters the expression of genes involved in the endocannabinoid system in the bovine endometrium and increases plasma progesterone concentrations (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262886 Marijuana Use and Its Effects in Pregnancy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27263998
Heparin exerts anti-apoptotic effects on uterine explants by targeting the endocannabinoid system (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364950
A role for the endocannabinoid system in premature luteal regression and progesterone withdrawal in lipopolysaccharide-induced early pregnancy loss model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27470501
Endocannabinoids participate in placental apoptosis induced by hypoxia inducible factor- 1 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488203
The endocannabinoid anandamide impairs in vitro decidualization of human cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568210
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal / early postnatal history (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27634313
Bisphenol A induces hypothalamic down-regulation of CB1 and anorexigenic effects in male mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27641926
Peripheral Blood Mononuclear Cells Infiltration Downregulates Decidual FAAH Activity in an LPS-Induced Embryo Resorption Model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27731508
A role for the endocannabinoid system in premature luteal regression and progesterone withdrawal in lipopolysaccharide-induced early pregnancy loss model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27470501
Evaluating a switch from meconium to umbilical cord tissue for newborn drug testing: A retrospective study at an academic medical center (abst–2016) http://www.sciencedirect.com/science/article/pii/S0009912016306087
Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27959272
Developmental Patterns of Adolescent Marijuana and Alcohol Use and Their Joint Association with Sexual Risk Behavior and Outcomes in Young Adulthood (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28083726


PRIONS
Alteration of the Endocannabinoid System In Mouse Brain During Prion Disease (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21195746/abstract/Alteration_of_the_Endocannabinoid_System_In_Mouse_Brain_During_Prion_Disease


PROSTATIC HYPERPLASIA/BPH/ENLARGED PROSTATE GLAND
Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19733001
Distribution and Possible Function of Cannabinoid Receptor Subtype 1 in the Human Prostate*—An Inhibitory Role for Growth in the Human Prostate Cancer (full–2013) http://file.scirp.org/Html/12-5000121_31406.htm
Future direction in pharmacotherapy for non-neurogenic male lower urinary tract symptoms (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23711541
Stimulation of cannabinoid receptors by using Rubus coreanus extracts to control osteoporosis in aged male rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25136745
A survey of cannabis (marijuana) use and self-reported benefit in men with chronic prostatitis/chronic pelvic pain syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25553163


PRURITIS
The Management of Chronic Pruritus in the Elderly (full–2010) http/www.skintherapyletter.com/2010/15.8/2.html
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action (full–2011) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3606913/
Is there a legitimate role for the therapeutic use of cannabinoids for symptom management in chronic kidney disease? (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21269798
Endocannabinoid signaling and epidermal differentiation (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21628127
Differences in peripheral endocannabinoid modulation of scratching behavior in facial vs spinally-innervated skin (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3394407/
Discovery of S-444823, a potent CB1/CB2 dual agonist as an antipruritic agent (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22421019
top
Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22444677
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation (full–2013) http/www.ncbi.nlm.nih.gov/pmc/articles/PMC3730365/
Low dose naloxone attenuates the pruritic but not anorectic response to rimonabant in male rats (abst–2013) http/www.ncbi.nlm.nih.gov/pubmed/23142959
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2012) http/www.ncbi.nlm.nih.gov/pubmed/22697514?
Understanding itch: An update on mediators and mechanisms of pruritus (full–2014) http/www.ijdvl.com/article.asp?issn=0378-6323;year=2014;volume=80;issue=2;spage=106;epage=114;aulast=Hassan
Evaluation of sex differences in cannabinoid dependence (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24582909
Blockade of cannabinoid CB1 and CB2 receptors does not prevent the antipruritic effect of systemic paracetamol (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24399199
The effect of propofol on intrathecal morphine-induced pruritus and its mechanism (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24445631
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24750433
Attenuation of serotonin-induced itch responses by inhibition of endocannabinoid degradative enzymes, fatty acid amide hydrolase and monoacylglycerol lipase (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24915981
S-777469, a Novel Cannabinoid Type 2 Receptor Agonist, Suppresses Itch-Associated Scratching Behavior in Rodents through Inhibition of Itch Signal Transmission (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25721168
Uremic Pruritus Is Not Associated with Endocannabinoid Receptor 1 Gene Polymorphisms (full–2016) http://www.hindawi.com/journals/bmri/2016/3567527/
The Gut-Itch Connection (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/exd.12994/full
Systemic and spinal administration of FAAH, MAGL inhibitors and dual FAAH/MAGL inhibitors produce antipruritic effect in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27126057
Cannabis and Dr Piffard-A Century Ahead of the Curve (article–2016) http://archderm.jamanetwork.com/article.aspx?articleid=2547236
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27720681 Descending serotonergic and noradrenergic systems do not regulate the antipruritic effects of cannabinoids (abst–2016) https://www.cambridge.org/core/journals/acta-neuropsychiatrica/article/descending-serotonergic-andnoradrenergic-systems-do-not-regulate-the-antipruritic-effects-ofcannabinoids/5BE6C9C7BA28268807D522354F70199A
The Endocannabinoid System and Its Role in Eczematous Dermatoses (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/28098721


PSEUDOMONAS AERUGINOSA
Discovery of Desketoraloxifene Analogues as Inhibitors of Mammalian, Pseudomonas aeruginosa, and NAPE Phospholipase D Enzymes (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336625/


PSORIASIS
Patent application title: PHARMACOLOGICAL TREATMENT OF PSORIASIS (full–2010) http/www.faqs.org/patents/app/20080255224
Endocannabinoid signaling and epidermal differentiation. (abst–2011) http/www.ncbi.nlm.nih.gov/pubmed/21628127
Cannabinoid Treatment for Psoriasis Symptoms (article–2012) http/medicalmarijuana.com/medical-marijuana-treatments/Psoriasis
A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ (full–2013) https/peerj.com/articles/40/
Effect of narrowband ultraviolet B treatment on endocannabinoid plasma levels in psoriasis patients (abst–2014) http/onlinelibrary.wiley.com/doi/10.1111/bjd.12916/abstract
Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases? (abst–2014) http/www.ncbi.nlm.nih.gov/pubmed/24823963
top
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model (full–2016) http://anndermatol.org/DOIx.php?id=10.5021/ad.2016.28.1.22
Cannabis for refractory psoriasis-high hopes for a novel treatment and a literature review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27164964
Anandamide Suppresses Proinflammatory T Cell Responses In Vitro through Type-1 Cannabinoid Receptor-Mediated mTOR Inhibition in Human Keratinocytes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27694494
Cannabinoids: Possible agents for treatment of psoriasis via suppression of angiogenesis and inflammation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28110689


Advertisements